Processing 00000000.tx.1: Quantitative Trait Loci Near the Insulin-Degrading Enzyme (IDE) Gene Contribute to Variation in Plasma Insulin Levels Harvest F. 

Phrase: "Quantitative Trait Loci Near the Insulin-Degrading Enzyme (IDE) Gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0597336:Quantitative Trait Loci [Gene or Genome]
   745   C1708726:Gene Locus [Gene or Genome]
           Locus
   742   C0392762:Quantitative [Quantitative Concept]
   742   C0599883:Trait [Organism Attribute]

Phrase: "Contribute to Variation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205419:Variation [Qualitative Concept]
   790   C1880177:Contribute [Activity]

Phrase: "in Plasma Insulin Levels Harvest F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   804   C0439133:(f) [Intellectual Product]
   804   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.2: Gu1, Suad Efendic1, Sofia Nordman1, Claes-Gran stenson1, Kerstin Brismar1, Anthony J. 

Phrase: "Gu1,"

Phrase: "Suad Efendic1,"

Phrase: "Sofia Nordman1,"

Phrase: "Claes-Gran stenson1,"

Phrase: "Kerstin Brismar1,"

Phrase: "Anthony J."
Processing 00000000.tx.3: Brookes2, and Jonathan A. 

Phrase: "Brookes2,"

Phrase: "and"

Phrase: "Jonathan A."
Processing 00000000.tx.4: Prince2 1 Department of Molecular Medicine, Rolf Luft Center for Diabetes Research, Karolinska Hospital, Stockholm, Sweden 2 Center for Genomics and Bioinformatics, Karolinska Institute, Stockholm, Sweden  ABSTRACT TOP ABSTRACT RESEARCH DESIGN AND METHODS REFERENCES  Insulin-degrading enzyme (IDE) plays a principal role in the proteolysis of several peptides in addition to insulin and is encoded by IDE, which resides in a region of chromosome 10q that is linked to type 2 diabetes. 

Phrase: "Prince2 1 Department of Molecular Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "Rolf Luft Center for Diabetes Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0683939:center research [Manufactured Object,Organization]
   753   C0205099:Center [Spatial Concept]

Phrase: "Karolinska Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Stockholm,"

Phrase: "Sweden 2 Center for Genomics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Bioinformatics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1140694:Bio-Informatics [Biomedical Occupation or Discipline]

Phrase: "Karolinska Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Stockholm,"

Phrase: "Sweden  ABSTRACT TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a principal role in the proteolysis of several peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "in addition to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "is"

Phrase: "encoded by IDE,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0679058:encoded [Mental Process]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C2700640:Encoded [Activity]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "which"

Phrase: "resides in a region of chromosome 10q"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C1953345:Region of chromosome [Cell]
           Chromosome region
   748   C0008633:Chromosome [Cell Component]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]
   748   C1520266:10q [Nucleotide Sequence]
   748   C2982691:Reside [Activity]

Phrase: "that"

Phrase: "is"

Phrase: "linked to type 2 diabetes."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
Processing 00000000.tx.5: Two recent studies presented genetic association data on IDE and type 2 diabetes (one positive and the other negative), but neither explored the fundamental question of whether polymorphism in IDE has a measurable influence on insulin levels in human populations. 

Phrase: "Two recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "genetic association data on IDE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]
   746   C3641102:Data Origin [Idea or Concept]

Phrase: "and"

Phrase: "type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(one positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "the other negative"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205160:Negative [Qualitative Concept]
  1000   C1513916:Negative [Finding]
  1000   C2825415:Negative [Conceptual Entity]
  1000   C2825491:Negative [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "neither"

Phrase: "explored"

Phrase: "the fundamental question of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1522634:Question [Intellectual Product]

Phrase: "whether"

Phrase: "polymorphism in IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032529:Polymorphism [Genetic Function]
   760   C1882417:Polymorphism [Qualitative Concept]

Phrase: "has"

Phrase: "a measurable influence on insulin levels"

Phrase: "in human populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.6: To address this possibility, 14 single nucleotide polymorphisms (SNPs) from a linkage disequilibrium block encompassing IDE have been genotyped in a sample of 321 impaired glucose tolerant and 403 nondiabetic control subjects. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this possibility,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "14 single nucleotide polymorphisms (SNPs) from a linkage disequilibrium block encompassing IDE"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   766   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   749   C1883037:Single Linkage [Research Activity]
   735   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   735   C0032529:polymorphisms [Genetic Function]
   735   C0037179:Single [Population Group]
   735   C0087136:single [Finding]
   735   C0205171:Single [Quantitative Concept]
   702 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "genotyped in a sample of 321 impaired glucose"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   789   C0555170:Glucose in sample [Laboratory or Test Result]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0221099:Impaired [Functional Concept]
   744   C0370003:Sample [Substance]
   744   C0684336:Impaired [Pathologic Function]
   744   C2347026:Sample [Conceptual Entity]
   711   C0017431:Genotype [Organism Attribute]

Phrase: "tolerant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231198:Tolerant [Functional Concept]

Phrase: "and"

Phrase: "403 nondiabetic control subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]
Processing 00000000.tx.7: Analyses based on haplotypic genotypes (diplotypes), constructed with SNPs that differentiate common extant haplotypes extending across IDE, provided compelling evidence of association with fasting insulin levels (P = 0.0009), 2-h insulin levels (P = 0.0027), homeostasis model assessment of insulin resistance (P = 0.0001), and BMI (P = 0.0067), with effects exclusively evident in men. 

Phrase: "Analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "based on haplotypic genotypes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0017431:Genotypes [Organism Attribute]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(diplotypes"

Phrase: ")"

Phrase: ","

Phrase: "constructed with SNPs"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   760   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0032529:polymorphisms [Genetic Function]
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   726 E C1882417:Polymorphism [Qualitative Concept]
   726   C2827421:Construct [Classification]

Phrase: "that"

Phrase: "differentiate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205615:differentiate [Qualitative Concept]

Phrase: "common extant haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018591:Haplotypes [Organism Attribute]

Phrase: "extending across IDE,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0439792:Extending [Spatial Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C0231448:Extend [Functional Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "provided compelling evidence of association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "with fasting insulin levels"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   827   C0015663:Fasting [Finding]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1550565:fasting [Intellectual Product]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C0456962:Fast [Qualitative Concept]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(P = 0.0009"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "2-h insulin levels"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   902   C0456948:2 levels [Intellectual Product]
   861   C0202098:insulin levels [Laboratory Procedure]
   861   C0428405:insulin levels [Laboratory or Test Result]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0441889:Levels [Qualitative Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(P = 0.0027"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "homeostasis model assessment of insulin resistance"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   985   C3639411:Homeostatic Model Assessment of Insulin Resistance [Laboratory Procedure]
   833   C1829779:Homeostasis model assessment [Laboratory Procedure]
   833   C1830060:Homeostasis model assessment [Clinical Attribute]
   753   C0019868:Homeostasis [Biologic Function]
   753   C1261322:Assessment [Health Care Activity]
   753   C1516048:Assessment [Activity]
   753   C3161035:Model [Intellectual Product]

Phrase: "(P = 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "BMI (P = 0.0067"

Phrase: ")"

Phrase: ","

Phrase: "with effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "exclusively evident in men."
Processing 00000000.tx.8: The strongest evidence for an effect of a single marker was obtained for rs2251101 (located near the 3' untranslated region of IDE) on 2-h insulin levels (P = 0.000023). 

Phrase: "The strongest evidence for an effect of a single marker"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "was"

Phrase: "obtained for rs2251101"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "("

Phrase: "located near the 3' untranslated region of IDE"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   782   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   782   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0014442:Enzyme [Enzyme,Organic Chemical]
   739   C0017446:Region [Geographic Area]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0205147:Region [Spatial Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]

Phrase: ")"

Phrase: "on 2-h insulin levels"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   902   C0456948:2 levels [Intellectual Product]
   861   C0202098:insulin levels [Laboratory Procedure]
   861   C0428405:insulin levels [Laboratory or Test Result]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0441889:Levels [Qualitative Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(P = 0.000023"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.9: Diplotype analyses, however, suggest the presence of multiple interacting trait-modifying sequences in the region. 

Phrase: "Diplotype analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "however,"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the presence of multiple interacting trait-modifying sequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the region."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.10: Results indicate that polymorphism in/near IDE contributes to a large proportion of variance in plasma insulin levels and correlated traits, but questions of sex specificity and allelic heterogeneity will need to be taken into consideration as the molecular basis of the observed phenotypic effects unfolds. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "in/near IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:In [Quantitative Concept]
   760   C0332285:In [Spatial Concept]

Phrase: "contributes to a large proportion of variance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0549177:Large [Quantitative Concept]
   748   C1709707:Proportion [Quantitative Concept]
   748   C1711260:Variance [Qualitative Concept]
   748   C1880177:Contribute [Activity]
   748   C2348152:Variance [Quantitative Concept]

Phrase: "in plasma insulin levels"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   966   C1276042:Plasma insulin level [Laboratory Procedure]
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   901   C0857690:plasma insulin [Laboratory Procedure]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "correlated traits,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0599883:traits [Organism Attribute]
   861   C1427926:TRAITS [Gene or Genome]

Phrase: "but"

Phrase: "questions of sex specificity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0009253:Sex [Organism Function]
   770   C0036864:Sex [Behavior]
   770   C0037791:Specificity [Quantitative Concept]
   770   C0079399:sex [Organism Attribute]
   770   C1314687:Sex [Finding]
   770   C1511884:Specificity [Quantitative Concept]
   770   C1522384:sex [Organism Attribute]
   770   C1522634:Question [Intellectual Product]

Phrase: "and"

Phrase: "allelic heterogeneity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C2986469:Allelic Heterogeneity [Qualitative Concept]
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]

Phrase: "will"

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "taken into consideration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0518609:consideration [Finding]
   790   C1883727:Taken [Conceptual Entity]
   756 E C1515187:Take [Health Care Activity]

Phrase: "as the molecular basis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1853126:MOLECULAR BASIS [Idea or Concept]
   861   C1527178:Basis [Functional Concept]
   861   C1874451:Basis [Pharmacologic Substance]

Phrase: "of the observed phenotypic effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "unfolds."
Processing 00000000.tx.11: The gene encoding insulin-degrading enzyme (IDE) is located on chromosome 10q23-q24, within a region linked to type 2 diabetes and related quantitative traits (14 ). 

Phrase: "The gene encoding insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   884   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C0014445:enzymes [Functional Concept]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "is"

Phrase: "located on chromosome 10q23-q24,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1520280:10q23-q24 [Cell Component]
   760   C0008633:Chromosome [Cell Component]

Phrase: "within a region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "linked to type 2 diabetes"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "related quantitative traits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0599883:traits [Organism Attribute]
   827   C1427926:TRAITS [Gene or Genome]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.12: IDE is the major enzyme responsible for insulin proteolysis in vitro (5) and shares structural and functional homology with bacterial protease III, which may function in the termination of the insulin response (6,7). 

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "the major enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "responsible for insulin proteolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "shares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "structural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structural [Spatial Concept]

Phrase: "and"

Phrase: "functional homology with bacterial protease III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1334043:Homology [Gene or Genome]
   753   C2697616:Homology [Qualitative Concept]

Phrase: "which"

Phrase: "may"

Phrase: "function in the termination of the insulin response"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C0871261:Response [Organism Attribute]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1549081:Termination [Intellectual Product]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1692758:termination [Idea or Concept]
   744   C1704632:Response [Finding]
   744   C1705273:Function [Intellectual Product]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.13: In mice, IDE hypofunction induced by IDE gene disruption leads to hyperinsulinemia (8). 

Phrase: "In mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "IDE hypofunction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0679221:hypofunction [Pathologic Function]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "induced by IDE gene disruption"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   778   C1333402:Enzyme Gene [Gene or Genome]
   774   C1337112:Insulin Gene [Gene or Genome]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0017337:Gene [Gene or Genome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0205263:Induced [Functional Concept]
   748   C0332453:Disruption [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "leads to hyperinsulinemia"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0020459:Hyperinsulinaemia [Disease or Syndrome]
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0181586:leads [Medical Device]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.14: Furthermore, IDE activity in the diabetic Goto-Kakizaki (GK) rat is reduced by 30%, where polymorphism in IDE is likely to be the main contributing factor (9). 

Phrase: "Furthermore,"

Phrase: "IDE activity in the diabetic Goto-Kakizaki (GK) rat"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0243102:enzyme activity [Molecular Function]
   757   C1145751:insulin activity [Molecular Function]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "reduced by 30%,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "where polymorphism in IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032529:Polymorphism [Genetic Function]
   753   C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "the main contributing factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.15: Congruence of positional and functional data indicates that sequence variation in IDE may play a role in modifying insulin metabolism in human populations. 

Phrase: "Congruence of positional"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0439853:Congruent [Qualitative Concept]

Phrase: "and"

Phrase: "functional data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "indicates"

Phrase: "that sequence variation in IDE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0042333:Sequence Variation [Natural Phenomenon or Process]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0205419:Variation [Qualitative Concept]
   748   C1519249:Sequence [Functional Concept]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in modifying insulin metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in human populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.16: Two recent genetic association studies investigated the IDE region in relation to type 2 diabetes. 

Phrase: "Two recent genetic association studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   884   C2717878:Genetic Association Studies [Molecular Biology Research Technique]
   836   C2827447:Genetic Study [Research Activity]
   804   C0947630:studies [Laboratory Procedure]
   771 E C0557651:Study [Manufactured Object]
   771 E C2603343:Study [Research Activity]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the IDE region in relation to type 2 diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0017446:Region [Geographic Area]
   738   C0205147:Region [Spatial Concept]
Processing 00000000.tx.17: One produced significant evidence for effects on both type 2 diabetes and plasma glucose levels (10), whereas the other explored only case-control models and obtained no evidence of association (11). 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "produced"

Phrase: "significant evidence for effects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "on both type 2 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "plasma glucose levels"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   966   C0455280:plasma glucose level [Laboratory or Test Result]
           plasma glucose
   901   C0202042:Plasma glucose [Laboratory Procedure]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the other explored only case-control models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3161035:Models [Intellectual Product]

Phrase: "and"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "no evidence of association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.18: Neither of these studies, however, attempted to directly relate IDE variants to measures of insulin metabolism. 

Phrase: "Neither of these studies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0947630:studies [Laboratory Procedure]
   770   C3274651:Neither [Qualitative Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "however,"

Phrase: "attempted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516084:Attempt [Event]

Phrase: "to directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883351:To [Qualitative Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "relate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0163712:Relate [Organic Chemical]

Phrase: "IDE variants to measures of insulin metabolism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205419:variants [Qualitative Concept]
Processing 00000000.tx.19: To evaluate the potential influence of genetic variation in IDE on insulin levels and correlated quantitative traits, a haplotype-tagging strategy was used (12) in a Swedish sample consisting of 321 impaired glucose tolerance (IGT) and 403 nondiabetic control subjects (Table 1). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the potential influence of genetic variation"

Phrase: "in IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "on insulin levels"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0202098:insulin levels [Laboratory Procedure]
  1000   C0428405:insulin levels [Laboratory or Test Result]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441889:Levels [Qualitative Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "correlated quantitative traits,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0599883:traits [Organism Attribute]
   827   C1427926:TRAITS [Gene or Genome]

Phrase: "a haplotype-tagging strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0679199:strategy [Mental Process]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "(12"

Phrase: ")"

Phrase: "in a Swedish sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "consisting of 321 impaired glucose tolerance (IGT)"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0271650:Impaired glucose tolerance [Disease or Syndrome]
   790   C0178665:Glucose tolerance [Physiologic Function]
   753   C0013220:Tolerance [Finding]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0020963:Tolerance [Pathologic Function]
   753   C0220929:tolerance [Mental Process]
   753   C0221099:Impaired [Functional Concept]
   753   C0231197:Tolerance [Physiologic Function]
   753   C0684336:Impaired [Pathologic Function]
   753   C1704410:Tolerance [Qualitative Concept]
   719   C0332529:CONSIST [Qualitative Concept]

Phrase: "and"

Phrase: "403 nondiabetic control subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.20: This study follows a recent report (13) in which we examined 26 polymorphic markers extending across IDE in relation to Alzheimers disease in a large Swedish population. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "a recent report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "(13"

Phrase: ")"

Phrase: "in which"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "26 polymorphic markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0005516:Marker [Clinical Attribute]

Phrase: "extending across IDE"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0439792:Extending [Spatial Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C0231448:Extend [Functional Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in relation to Alzheimers disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "in a large Swedish population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
Processing 00000000.tx.21: These were used to define regional linkage disequilibrium (LD) structure, which highlighted a LD block spanning 276 kb around IDE. 

Phrase: "These"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "regional linkage disequilibrium (LD) structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0678594:Structure [Spatial Concept]

Phrase: "which"

Phrase: "highlighted"

Phrase: "a LD block"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0028778:Block [Pathologic Function]
   827   C0332206:Block [Functional Concept]
   827   C1533157:Block [Substance]
   827   C1706084:Block [Geographic Area]
   827   C2828370:Block [Quantitative Concept]
   755 E C2983591:BLOCKED [Research Activity]
   734   C0023746:Linkage Disequilibrium [Quantitative Concept]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "276 kb around IDE."
Processing 00000000.tx.22: Three single nucleotide polymorphism (SNP) markers were identified as capable of delineating common haplotypes (>5%) in Swedes and were subsequently used in tests of association. 

Phrase: "Three single nucleotide polymorphism (SNP) markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0005516:Marker [Clinical Attribute]
   717   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]

Phrase: "were"

Phrase: "identified as capable of delineating common haplotypes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0018591:Haplotypes [Organism Attribute]
   748   C0205214:Common [Quantitative Concept]
   748   C0205396:Identified [Qualitative Concept]
   748   C1522138:Common [Functional Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   748   C3245511:common [Intellectual Product]

Phrase: "("

Phrase: ">5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "in Swedes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0337818:Swedes [Population Group]
   966 E C0349379:Swede [Food]

Phrase: "and"

Phrase: "were"

Phrase: "subsequently"

Phrase: "used in tests of association."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   781   C1524063:Use of [Functional Concept]
   760   C0004083:Association [Mental Process]
   760   C0022885:Tests [Laboratory Procedure]
   760   C0392366:Tests [Intellectual Product]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]
   760   C1273517:used [Finding]
   726 E C0039593:Test [Functional Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.23: View this table: [in this window] [in a new window]  TABLE 1 Clinical characteristics of the IGT and nondiabetic control subjects  For the present study, 14 SNP markers extending locally across IDE were examined (Fig. 1), including previously identified tag markers. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 Clinical characteristics of the IGT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0683325:clinical characteristics [Clinical Attribute]
   742   C1521970:Characteristics [Qualitative Concept]

Phrase: "and"

Phrase: "nondiabetic control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "subjects  For the present study,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   797   C0681850:Study Subject [Group]
           Subject
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1706203:Subject [Idea or Concept]
   760   C2349001:Subject [Human]
   760   C2603343:Study [Research Activity]
   760   C2697811:Subject [Functional Concept]

Phrase: "14 SNP markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0005516:Marker [Clinical Attribute]
   717   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]

Phrase: "extending"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439792:Extending [Spatial Concept]
   966 E C0231448:Extend [Functional Concept]

Phrase: "locally across IDE"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1517927:Locally [Spatial Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "were"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "previously identified tag markers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.24: We began by genotyping these in the entire male sample to define LD structure and to identify common haplotypes. 

Phrase: "We"

Phrase: "began by genotyping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1285573:Genotyping [Laboratory Procedure]
   756   C0439659:Begin [Temporal Concept]

Phrase: "these in the entire male"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C1284842:Entire male [Organism Attribute]
   760   C0024554:Male [Finding]
   760   C0039828:these [Intellectual Product]
   760   C0086582:male [Population Group]
   760   C0439751:Entire [Quantitative Concept]
   760   C0444667:Entire [Quantitative Concept]
   760   C1706180:Male [Qualitative Concept]
   760   C1706428:Male [Qualitative Concept]
   760   C1706429:Male [Organism Attribute]

Phrase: "sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "LD structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0678594:Structure [Spatial Concept]
   734   C0023746:Linkage Disequilibrium [Quantitative Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "common haplotypes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]
Processing 00000000.tx.25: All 14 markers were found to be in Hardy-Weinberg equilibrium. 

Phrase: "All 14 markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be in Hardy-Weinberg equilibrium."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0014653:Equilibrium [Organism Function]
   760   C1547026:Equilibrium [Quantitative Concept]
   760   C2987476:Be [Conceptual Entity]
Processing 00000000.tx.26: Pairwise marker correlations suggested strong LD in the region, in agreement with earlier data (13). 

Phrase: "Pairwise marker correlations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1707520:Correlation [Qualitative Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "strong LD in the region,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0023746:Linkage Disequilibrium [Quantitative Concept]
   753   C0023745:linkage [Molecular Function]
   753   C0281825:Disequilibrium [Finding]
   753   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with earlier data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.27: Common haplotypes (those >5% frequency), inferred with HAPLOTYPER using all 14 markers, were similar to those obtained based on a slightly modified marker set (13). 

Phrase: "Common haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "("

Phrase: "those"

Phrase: ">5% frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "inferred with HAPLOTYPER"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0679201:Inferred [Mental Process]
   790   C3245504:inferred [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "all 14 markers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "were"

Phrase: "similar to those obtained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "based on a slightly modified marker set (13"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   744   C0005516:Marker [Clinical Attribute]
   744   C0036849:Set [Mental Process]
   744   C0392747:Modified [Functional Concept]
   744   C0750482:Slightly [Idea or Concept]
   744   C1442518:Set [Functional Concept]
   744   C1527178:Based [Functional Concept]
   744   C1705195:Set [Conceptual Entity]
   744   C1705938:Based [Idea or Concept]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1880279:Base [Biomedical or Dental Material]

Phrase: ")."
Processing 00000000.tx.28: LD estimates and inferred haplotypes for the entire sample are shown in Figs. 

Phrase: "LD estimates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0750572:estimates [Quantitative Concept]
   734   C0023746:Linkage Disequilibrium [Quantitative Concept]

Phrase: "and"

Phrase: "inferred haplotypes for the entire sample"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0018591:Haplotypes [Organism Attribute]

Phrase: "are"

Phrase: "shown in Figs."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0349966:Figs [Food]
   756 E C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.29: 2 and 3, respectively. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "respectively."
Processing 00000000.tx.30: The definition of Patil et al. 

Phrase: "The definition of Patil et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1550452:definition [Idea or Concept]
   753   C1704788:Definition [Conceptual Entity]
   753   C3539107:Definition [Intellectual Product]
Processing 00000000.tx.31: (14) ( = 0.8) was used to confirm that the studied region does represent an LD block. 

Phrase: "(14"

Phrase: ")"

Phrase: "("

Phrase: "= 0.8"

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the studied region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "does"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an LD block."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0028778:Block [Pathologic Function]
   827   C0332206:Block [Functional Concept]
   827   C1533157:Block [Substance]
   827   C1706084:Block [Geographic Area]
   827   C2828370:Block [Quantitative Concept]
   755 E C2983591:BLOCKED [Research Activity]
   734   C0023746:Linkage Disequilibrium [Quantitative Concept]
Processing 00000000.tx.32: We also confirmed that a selection of three tag markers equivalent to those previously used (13) would be able to delineate common haplotypes and opted not to explore the use of alternative equally valid marker sets. 

Phrase: "We also"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "a selection of three tag markers equivalent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0036576:selection [Genetic Function]

Phrase: "to those previously"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "(13"

Phrase: ")"

Phrase: "would"

Phrase: "be"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "delineate"

Phrase: "common haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "and"

Phrase: "opted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1412930:OPT [Gene or Genome]

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "explore"

Phrase: "the use of alternative equally valid marker sets."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1524063:Use of [Functional Concept]
   744   C0042153:use [Functional Concept]
   744   C0457083:Use [Functional Concept]
   744   C1947944:Use [Intellectual Product]
Processing 00000000.tx.33: We note that a variety of different approaches exist for defining optimal SNP sets (15), but we have not explored their use here. 

Phrase: "We"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "a variety of different approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "exist for defining optimal SNP sets"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]
   744   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0032529:Polymorphism [Genetic Function]
   744   C0036849:Set [Mental Process]
   744   C0037179:Single [Population Group]
   744   C0087136:single [Finding]
   744   C0205171:Single [Quantitative Concept]
   744   C1442518:Set [Functional Concept]
   744   C1705195:Set [Conceptual Entity]
   744   C1882417:Polymorphism [Qualitative Concept]
   744   C2698651:Optimal [Qualitative Concept]
   744   C2987476:Exist [Conceptual Entity]

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "we"

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "explored"

Phrase: "their use here."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0042153:use [Functional Concept]
   861   C0457083:Use [Functional Concept]
   861   C1947944:Use [Intellectual Product]
Processing 00000000.tx.34: These and other issues may have relevance for attempts at replicating or refuting the present data, as LD structures can differ markedly between divergent populations (K.K. Kidd, A.J.B., personal communication). 

Phrase: "These"

Phrase: "and"

Phrase: "other issues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0033213:Issue [Finding]
   966   C1706387:Issue [Intellectual Product]

Phrase: "may"

Phrase: "have"

Phrase: "relevance for attempts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2347946:Relevance [Qualitative Concept]

Phrase: "at replicating"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205173:replicating [Functional Concept]
   966 E C0205341:Replicate [Functional Concept]
   966 E C1883725:Replicate [Qualitative Concept]

Phrase: "or"

Phrase: "refuting"

Phrase: "the present data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "as"

Phrase: "LD structures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0678594:structures [Spatial Concept]
   734   C0023746:Linkage Disequilibrium [Quantitative Concept]

Phrase: "can"

Phrase: "differ"

Phrase: "markedly between divergent populations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0032659:Population [Quantitative Concept]
   770   C0522501:Markedly [Qualitative Concept]
   770   C1257890:Population [Population Group]

Phrase: "(K.K. Kidd,"

Phrase: "A.J.B.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1440044:A,B [Immunologic Factor]
   734   C1510707:A/J [Mammal]

Phrase: "personal communication"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086792:Personal Communication [Social Behavior]
   861   C0009452:Communication [Social Behavior]

Phrase: ")."
Processing 00000000.tx.35: View larger version (48K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(48K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.36: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.37: Details of examined SNPs in IDE.  

Phrase: "Details of examined SNPs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1522508:Details [Qualitative Concept]
   719 E C1561567:detail [Functional Concept]

Phrase: "in IDE."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.38: View larger version (68K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(68K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.39: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.40: Pairwise LD for 14 SNP markers extending across IDE.  

Phrase: "Pairwise LD for 14 SNP markers"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0023746:Linkage Disequilibrium [Quantitative Concept]
   762   C1883037:Single Linkage [Research Activity]
   742   C0023745:linkage [Molecular Function]
   742   C0281825:Disequilibrium [Finding]
   742   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "extending across IDE."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0439792:Extending [Spatial Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C0231448:Extend [Functional Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.41: View larger version (24K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.42: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.43: Common haplotypes extending across IDE.  

Phrase: "Common haplotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotypes [Organism Attribute]

Phrase: "extending across IDE."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0439792:Extending [Spatial Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C0231448:Extend [Functional Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.44: For initial analyses, our intention was to reduce the number of exploratory tests by examining a critical set of phenotypes against a limited number of haplotypic genotypes (also referable to as diplotypesfor brevity, we have opted to use the latter term throughout this report). 

Phrase: "For initial analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "our intention"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0162425:Intention [Mental Process]
  1000   C1283828:Intention [Qualitative Concept]
   900 E C0679198:intentionality [Idea or Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "the number of exploratory tests"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "by examining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332128:examining [Finding]
  1000   C2004054:Examining [Activity]

Phrase: "a critical set of phenotypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036849:Set [Mental Process]
   760   C1442518:Set [Functional Concept]
   760   C1705195:Set [Conceptual Entity]

Phrase: "against a limited number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "of haplotypic genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotypes [Organism Attribute]

Phrase: "(also referable to"

Phrase: "as"

Phrase: "diplotypesfor brevity,"

Phrase: "we"

Phrase: "have"

Phrase: "opted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1412930:OPT [Gene or Genome]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "the latter term throughout this report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1515273:Term [Temporal Concept]
   753   C1705313:Term [Idea or Concept]
   753   C2826302:TERM [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.45: The principal criterion for diplotype construction is that they can be inferred with high probability and thus reflect with fidelity combinations of common haplotypes for each individual. 

Phrase: "The principal criterion for diplotype construction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0243161:Criterion [Intellectual Product]

Phrase: "is"

Phrase: "that"

Phrase: "they"

Phrase: "can"

Phrase: "be"

Phrase: "inferred with high probability"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033204:Probability [Quantitative Concept]
   770   C0205250:High [Qualitative Concept]
   770   C0679201:Inferred [Mental Process]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]
   770   C3245504:inferred [Idea or Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "reflect with fidelity combinations of common haplotypes"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   748   C0018591:Haplotypes [Organism Attribute]
   748   C0205214:Common [Quantitative Concept]
   748   C0453882:Combinations [Manufactured Object]
   748   C0558058:reflect [Mental Process]
   748   C0680011:fidelity [Social Behavior]
   748   C1522138:Common [Functional Concept]
   748   C3245511:common [Intellectual Product]
   714 E C0205195:Combination [Qualitative Concept]
   714 E C1947911:Combination [Physical Object]

Phrase: "for each individual."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027361:Individual [Population Group]
  1000   C0237401:Individual [Human]
Processing 00000000.tx.46: In the presence of limited allelic heterogeneity, this can be advantageous over single marker tests, which can fail to detect effects due to insufficient or complex patterns of LD with pathogenic variants. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of limited allelic heterogeneity,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C2986469:Allelic Heterogeneity [Qualitative Concept]
   827   C0019409:Heterogeneity [Qualitative Concept]
   743 E C1512426:Heterogenous [Idea or Concept]

Phrase: "this"

Phrase: "can"

Phrase: "be"

Phrase: "advantageous over single marker tests,"

Phrase: "which"

Phrase: "can"

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "effects due to insufficient"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "complex patterns of LD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Patterns [Spatial Concept]

Phrase: "with pathogenic variants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:variants [Qualitative Concept]
Processing 00000000.tx.47: In addition, testing many single markers requires a substantial degree of multiple testing. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "testing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0039593:Testing [Functional Concept]
  1000   C0392366:testing [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]

Phrase: "many single markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "requires"

Phrase: "a substantial degree of multiple testing."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0441889:Degree [Qualitative Concept]
   753   C0449286:Degree [Quantitative Concept]
   753   C0542560:Degree [Intellectual Product]
   753   C1561545:degree [Quantitative Concept]
   753   C2348088:Degree [Quantitative Concept]
Processing 00000000.tx.48: Our selection of quantitative phenotypes for analyses included six traits typically examined in relation to diabetes (1618), and these are listed in Table 1. 

Phrase: "Our selection of quantitative phenotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036576:selection [Genetic Function]

Phrase: "for analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "six traits typically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0599883:traits [Organism Attribute]
   827   C1427926:TRAITS [Gene or Genome]

Phrase: "examined in relation to diabetes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0080103:Relation [Family Group]
   760   C0332128:Examined [Finding]
   760   C0869014:relation [Social Behavior]

Phrase: "(1618"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "these"

Phrase: "are"

Phrase: "listed in Table 1."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C0745732:List [Conceptual Entity]
   737   C3272378:LIST [Intellectual Product]
Processing 00000000.tx.49: We note that studies (19,20) that have investigated IDE in relation to diabetes did not report efforts to relate genotypes to either insulin levels or obesity. 

Phrase: "We"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "(19,"

Phrase: "20"

Phrase: ")"

Phrase: "that"

Phrase: "have"

Phrase: "investigated IDE in relation to diabetes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "efforts to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015264:Effort [Organism Function]

Phrase: "relate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0163712:Relate [Organic Chemical]

Phrase: "genotypes to either insulin levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017431:Genotypes [Organism Attribute]

Phrase: "or"

Phrase: "obesity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]
Processing 00000000.tx.50: Trait distributions were highly skewed or partially skewed for all six studied phenotypes, and thus only log-transformed data were modeled. 

Phrase: "Trait distributions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0037775:Distributions [Spatial Concept]
   827 E C0520511:distribution [Idea or Concept]
   827 E C1704711:Distribution [Functional Concept]

Phrase: "were"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "skewed"

Phrase: "or"

Phrase: "partially"

Phrase: "skewed for all six studied phenotypes,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0031437:Phenotypes [Organism Attribute]
   753   C0205452:Six [Quantitative Concept]
   719 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "and"

Phrase: "thus only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "log-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708728:Log [Intellectual Product]
  1000   C2986775:log [Occupational Activity]

Phrase: "transformed data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "modeled."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3161035:Model [Intellectual Product]
Processing 00000000.tx.51: Correlations between traits were extremely high, as was expected (data not shown). 

Phrase: "Correlations between traits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1707520:Correlation [Qualitative Concept]

Phrase: "were"

Phrase: "extremely high,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "as"

Phrase: "was"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.52: Diplotypes were inferred using the three selected haplotype-tagging markers (Fig. 3) and tested against all six traits highlighted in Table 1 in men and women separately. 

Phrase: "Diplotypes"

Phrase: "were"

Phrase: "inferred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679201:Inferred [Mental Process]
  1000   C3245504:inferred [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the three selected haplotype-tagging markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0005516:Marker [Clinical Attribute]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "tested against all six traits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0205452:Six [Quantitative Concept]
   760   C0392366:tested [Intellectual Product]
   760   C0599883:traits [Organism Attribute]
   760   C1427926:TRAITS [Gene or Genome]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "highlighted in Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]

Phrase: "in men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]

Phrase: "and"

Phrase: "women separately."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043210:Women [Population Group]
Processing 00000000.tx.53: Six of eight possible haplotypes are predicted using these markers, the sequences for which are H1-TCG, H2-TCA, H3-CCA, H4-TTA, H5-TTG, and H6-CCG. 

Phrase: "Six of eight possible haplotypes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0018591:Haplotypes [Organism Attribute]
   760   C0205452:Six [Quantitative Concept]
   760   C0205454:Eight [Quantitative Concept]
   760   C0332149:Possible [Qualitative Concept]
   760   C1705910:Possible [Qualitative Concept]
   760   C2362652:Possible [Qualitative Concept]

Phrase: "are"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "these markers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0005516:Marker [Clinical Attribute]

Phrase: "the sequences for which"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0162326:Sequences [Nucleotide Sequence]
   737 E C0004793:Sequence [Nucleotide Sequence]
   737 E C0162327:Sequence [Nucleotide Sequence]
   737 E C1519249:Sequence [Functional Concept]

Phrase: "are"

Phrase: "H1-TCG,"

Phrase: "H2-TCA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0041405:TCA [Geographic Area]
   861   C0085758:TCA [Congenital Abnormality]
   861   C1415587:TCA [Gene or Genome]
   861   C3536819:TCA [Pharmacologic Substance]

Phrase: "H3-CCA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220668:CCA [Congenital Abnormality]

Phrase: "H4-TTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1627773:TTA [Finding]

Phrase: "H5-TTG,"

Phrase: "and"

Phrase: "H6-CCG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516476:CCG [Health Care Related Organization]
Processing 00000000.tx.54: Posterior probability estimates were in excess of 0.80 for all phase calls that represent the various combinations of these haplotypes (a threshold that was set for retaining individuals for analyses). 

Phrase: "Posterior probability estimates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0750572:estimates [Quantitative Concept]

Phrase: "were in excess of 0.80"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1979886:Excess [Qualitative Concept]

Phrase: "for all phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205390:Phase [Temporal Concept]

Phrase: "calls"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0679006:Call [Mental Process]
  1000   C1947967:Call [Functional Concept]

Phrase: "that"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the various combinations of these haplotypes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0453882:Combinations [Manufactured Object]
   719 E C0205195:Combination [Qualitative Concept]
   719 E C1947911:Combination [Physical Object]

Phrase: "("

Phrase: "a threshold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449864:Threshold [Qualitative Concept]

Phrase: "that"

Phrase: "was"

Phrase: "set for retaining individuals"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0036849:Set [Mental Process]
   770   C0333118:retaining [Functional Concept]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]
   737   C0027361:Individual [Population Group]
   737   C0237401:Individual [Human]

Phrase: "for analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: ")."
Processing 00000000.tx.55: Significant and consistent effects upon traits were evident, with the notable exception of fasting glucose and 2-h glucose levels. 

Phrase: "Significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "and"

Phrase: "consistent effects upon traits"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "evident,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0332120:Evidence [Functional Concept]

Phrase: "with the notable exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1554961:exception [Idea or Concept]
   861   C1705847:Exception [Conceptual Entity]

Phrase: "of fasting glucose"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0015663:Fasting [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1550565:fasting [Intellectual Product]
   827 E C0456962:Fast [Qualitative Concept]

Phrase: "and"

Phrase: "2-h glucose levels."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   902   C0456948:2 levels [Intellectual Product]
   861   C0428548:glucose levels [Laboratory or Test Result]
   827 E C0337438:glucose level [Laboratory Procedure]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.56: Importantly, effects were evident exclusively in men, which are in agreement with results obtained by Karamohamed et al. 

Phrase: "Importantly,"

Phrase: "effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "evident exclusively in men,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0025266:Men [Population Group]
   737 E C0024554:MAN [Finding]
   737 E C0086418:Man [Human]

Phrase: "which"

Phrase: "are in agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0680240:Agreement [Social Behavior]
   790   C1551058:Are [Quantitative Concept]

Phrase: "with results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "obtained by Karamohamed et al."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.57: (10). 

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.58: The results of these analyses are shown in Fig. 

Phrase: "The results of these analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.59: 4, where data for the male sample are presented. 

Phrase: "4,"

Phrase: "where data for the male sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.60: For all analyses, we combined IGT individuals and nondiabetic control subjects and adjusted for any uniform phenotypic differences between them by including their group identity as a factor in ANOVA models. 

Phrase: "For all analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "we"

Phrase: "combined"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]

Phrase: "IGT individuals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0027361:Individual [Population Group]
   779   C0237401:Individual [Human]
   756   C0271650:Impaired glucose tolerance [Disease or Syndrome]

Phrase: "and"

Phrase: "nondiabetic control subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "adjusted for any uniform phenotypic differences"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205375:Uniform [Qualitative Concept]
   753   C0456081:Adjusted [Functional Concept]
   753   C1608508:uniform [Quantitative Concept]
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "between them"

Phrase: "by"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "their group identity as a factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0424215:Identity [Mental Process]
   753   C2003939:Identity [Finding]

Phrase: "in ANOVA models."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]
Processing 00000000.tx.61: Diplotype by group interaction terms in second-order factorial ANOVA models were not significant. 

Phrase: "Diplotype by group interaction terms"

Phrase: "in second-order factorial ANOVA models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3161035:Models [Intellectual Product]

Phrase: "were"

Phrase: "not significant."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.62: As the above analyses are based on probabilistically inferred data, we considered it important to also explore models that only entail the use of phase-known data. 

Phrase: "As the above analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "are"

Phrase: "based on probabilistically inferred data,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   781   C0242356:data base [Intellectual Product]
   781   C0993637:Data Base [Intellectual Product]
   760   C0679201:Inferred [Mental Process]
   760   C1511726:Data [Idea or Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C3245479:data [Medical Device]
   760   C3245504:inferred [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "we"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "it important to also"

Phrase: "explore"

Phrase: "models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "that only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "entail"

Phrase: "the use of phase-known data."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]
Processing 00000000.tx.63: This can be accomplished by excluding individuals that are heterozygous at two or more sites (all individuals with only one heterozygote site are by definition phase known). 

Phrase: "This"

Phrase: "can"

Phrase: "be"

Phrase: "accomplished by excluding individuals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0027361:Individual [Population Group]
   737   C0237401:Individual [Human]
   737   C0332196:Exclude [Functional Concept]
   737   C2828389:Exclude [Activity]

Phrase: "that"

Phrase: "are"

Phrase: "heterozygous at two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0019425:Heterozygous [Organism Attribute]

Phrase: "or"

Phrase: "more sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "("

Phrase: "all individuals with only one heterozygote site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0027361:Individual [Population Group]
   714   C0237401:Individual [Human]

Phrase: "are by definition phase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205390:Phase [Temporal Concept]
   770   C1550452:definition [Idea or Concept]
   770   C1551058:Are [Quantitative Concept]
   770   C1704788:Definition [Conceptual Entity]
   770   C3539107:Definition [Intellectual Product]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.64: To demonstrate this, an additional analysis was performed in men on the four associated traits shown in Fig. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "this,"

Phrase: "an additional analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed in men"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0025266:Men [Population Group]
   790   C0884358:Performed [Functional Concept]
   756 E C0024554:MAN [Finding]
   756 E C0086418:Man [Human]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "on the four associated traits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0599883:traits [Organism Attribute]
   827   C1427926:TRAITS [Gene or Genome]

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.65: 4 (insulin, 2-h insulin, homeostasis model assessment of insulin resistance [HOMA-IR], and BMI). 

Phrase: "4"

Phrase: "(insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "2-h insulin,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
   734   C0011744:2 H [Element, Ion, or Isotope]

Phrase: "homeostasis model assessment of insulin resistance [HOMA-IR],"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   985   C3639411:Homeostatic Model Assessment of Insulin Resistance [Laboratory Procedure]
   833   C1829779:Homeostasis model assessment [Laboratory Procedure]
   833   C1830060:Homeostasis model assessment [Clinical Attribute]
   753   C0019868:Homeostasis [Biologic Function]
   753   C1261322:Assessment [Health Care Activity]
   753   C1516048:Assessment [Activity]
   753   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "BMI"

Phrase: ")."
Processing 00000000.tx.66: Results revealed association with all four of these, but significance was highest for BMI (F7,220 = 3.5; P = 0.0014) (data for other comparisons not shown). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "revealed association with all four of these,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "but"

Phrase: "significance"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0237881:Significance [Quantitative Concept]
  1000   C0750502:Significance [Idea or Concept]
   928 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "highest for BMI (F7,220"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1522410:Highest [Qualitative Concept]
   726 E C0205250:High [Qualitative Concept]
   726 E C1299351:High [Qualitative Concept]
   726 E C2700149:HIGH [Intellectual Product]

Phrase: "= 3.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442758:3 5 [Quantitative Concept]
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "; P = 0.0014"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(data for other comparisons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.67: For reference to Fig. 

Phrase: "For reference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "to Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.68: 4, the groups that are excluded in this analysis are H1/H3, H2/H5, H3/H4, and H3/H5. 

Phrase: "4,"

Phrase: "the groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "that"

Phrase: "are"

Phrase: "excluded in this analysis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C1554077:Excluded [Idea or Concept]
   770   C2828389:Excluded [Activity]
   737 E C0332196:Exclude [Functional Concept]

Phrase: "are"

Phrase: "H1/H3,"

Phrase: "H2/H5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538895:H5 [Gene or Genome]

Phrase: "H3/H4,"

Phrase: "and"

Phrase: "H3/H5."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538895:H5 [Gene or Genome]
Processing 00000000.tx.69: View larger version (114K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(114K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.70: 4. 

Phrase: "4."
Processing 00000000.tx.71: Diplotype association with quantitative traits in men. 

Phrase: "Diplotype association with quantitative traits"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "in men."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]
Processing 00000000.tx.72: Mean values (SE) for fasting glucose (A), 2-h glucose (B), fasting insulin (C), 2-h insulin (D), HOMA (E), and BMI (F) in men according to diplotype groups as estimated using HAPLOTYPER. 

Phrase: "Mean values"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0042295:Values [Qualitative Concept]
   861   C0444504:Mean [Quantitative Concept]
   861   C2347634:Mean [Quantitative Concept]
   861   C2348143:Mean [Quantitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "(SE) for fasting glucose"

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "2-h glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   734   C0011744:2 H [Element, Ion, or Isotope]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "fasting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015663:Fasting [Finding]
  1000   C1550565:fasting [Intellectual Product]
   966 E C0456962:Fast [Qualitative Concept]

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(C), 2-h insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "D)"

Phrase: ","

Phrase: "HOMA (E"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "BMI (F) in men"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   770   C0439133:(f) [Intellectual Product]
   770   C1553038:[f] [Quantitative Concept]

Phrase: "according to diplotype groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "as"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "HAPLOTYPER."
Processing 00000000.tx.73: Untransformed data are shown. 

Phrase: "Untransformed data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.74: Categories with less than six observations have been excluded. 

Phrase: "Categories with less"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0683312:Categories [Intellectual Product]
   756 E C1555713:category [Idea or Concept]

Phrase: "than six observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "have"

Phrase: "been"

Phrase: "excluded."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.75: F ratios from ANOVA omnibus tests (performed on log-transformed data for all traits) and associated P values are shown in the upper right corner of each diagram. 

Phrase: "F ratios from ANOVA omnibus tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0456603:Ratios [Quantitative Concept]
   753   C1610540:*Ratios [Quantitative Concept]
   719 E C1547037:Ratio [Intellectual Product]

Phrase: "("

Phrase: "performed on log-transformed data"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0884358:Performed [Functional Concept]
   760   C1510411:Transformed [Pathologic Function]
   760   C1511726:Data [Idea or Concept]
   760   C1708728:Log [Intellectual Product]
   760   C2986775:log [Occupational Activity]
   760   C3245479:data [Medical Device]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "for all traits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0599883:traits [Organism Attribute]
  1000   C1427926:TRAITS [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "associated P values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   867   C1709380:P-Value [Quantitative Concept]
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "shown in the upper right corner of each diagram."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0205090:Right [Spatial Concept]
   742   C0681494:Diagram [Intellectual Product]
   742   C1282910:Upper [Spatial Concept]
   742   C1879655:Corner - [Laboratory Procedure]
   742   C1879656:Corner + [Laboratory Procedure]
   708   C1547282:Show [Intellectual Product]
Processing 00000000.tx.76: The number of individuals in each category is shown at the base of each column.  

Phrase: "The number of individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "in each category"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0683312:Category [Intellectual Product]
  1000   C1555713:category [Idea or Concept]

Phrase: "is"

Phrase: "shown at the base of each column."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0002055:base [Inorganic Chemical]
   748   C0178499:Base [Chemical Viewed Functionally]
   748   C1185738:Column [Body Part, Organ, or Organ Component]
   748   C1706132:Column [Idea or Concept]
   748   C1880279:Base [Biomedical or Dental Material]
   714   C1547282:Show [Intellectual Product]
Processing 00000000.tx.77: In an attempt to refine the possible position of pathogenic variant(s) in the region, single marker tests were conducted on the phenotypes that provided evidence of association in diplotype models. 

Phrase: "In an attempt to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516084:Attempt [Event]

Phrase: "refine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   916   C1947930:Cleanse [Activity]
   916   C1998793:Purified [Functional Concept]

Phrase: "the possible position of pathogenic variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0733755:Position [Spatial Concept]

Phrase: "("

Phrase: "s) in the region,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]
   770   C2603362:S' [Clinical Attribute]

Phrase: "single marker tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022885:Tests [Laboratory Procedure]
   827   C0392366:Tests [Intellectual Product]
   793 E C0039593:Test [Functional Concept]

Phrase: "were"

Phrase: "conducted on the phenotypes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0031437:Phenotypes [Organism Attribute]
   737   C0004927:Conduct [Individual Behavior]
   737 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "that provided evidence of association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in diplotype models."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]
Processing 00000000.tx.78: In considering multiple testing issues, we noted that the strongest individual finding in HOMA-IR (P = 0.0001) affords 500 individual tests before strict multiple testing correction renders this finding insignificant (given = 0.05). 

Phrase: "In considering multiple testing issues,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0033213:Issue [Finding]
   779   C1706387:Issue [Intellectual Product]

Phrase: "we"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the strongest individual finding in HOMA-IR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0037088:Finding [Sign or Symptom]
   738   C0243095:Finding [Finding]
   738   C2825141:Finding [Finding]

Phrase: "(P = 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "affords"

Phrase: "500 individual tests before strict multiple testing correction"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   750   C0683443:test testing [Diagnostic Procedure]
   744   C0022885:Tests [Laboratory Procedure]
   744   C0392366:Tests [Intellectual Product]
   711 E C0039593:Test [Functional Concept]

Phrase: "renders"

Phrase: "this finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "insignificant"

Phrase: "(given"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]

Phrase: "= 0.05"

Phrase: ")."
Processing 00000000.tx.79: These tests, using all 14 markers, were performed only in the male sample because diplotype analyses gave us no a priori reason to suspect that latent associations for single markers would be present in the female set. 

Phrase: "These tests,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0022885:Tests [Laboratory Procedure]
  1000   C0392366:Tests [Intellectual Product]
   966 E C0039593:Test [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "all 14 markers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "only in the male sample"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0024554:Male [Finding]
   760   C0086582:male [Population Group]
   760   C0205171:Only [Quantitative Concept]
   760   C0370003:Sample [Substance]
   760   C1706180:Male [Qualitative Concept]
   760   C1706428:Male [Qualitative Concept]
   760   C1706429:Male [Organism Attribute]
   760   C1720467:Only [Intellectual Product]
   760   C2347026:Sample [Conceptual Entity]

Phrase: "because"

Phrase: "diplotype analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "us no a priori"

Phrase: "reason"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392360:Reason [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "suspect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750491:suspect [Idea or Concept]
  1000   C1571873:Suspect [Idea or Concept]

Phrase: "that latent associations for single markers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0004083:Associations [Mental Process]
   719 E C0439849:Association [Qualitative Concept]
   719 E C0596306:Association [Phenomenon or Process]
   719 E C0699792:association [Social Behavior]

Phrase: "would"

Phrase: "be"

Phrase: "present in the female set."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
Processing 00000000.tx.80: These results are shown in Fig. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.81: 5, where consistent effects of rs2251101 and rs2249960 can be seen upon traits. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "where consistent effects of rs2251101"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "rs2249960"

Phrase: "can"

Phrase: "be"

Phrase: "seen upon traits."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   790   C0599883:traits [Organism Attribute]
   790   C1427926:TRAITS [Gene or Genome]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
Processing 00000000.tx.82: The common allele at rs2251101 and the rare allele of rs2249960 were associated with lower trait levels. 

Phrase: "The common allele at rs2251101"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "the rare allele of rs2249960"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002085:Allele [Gene or Genome]

Phrase: "were"

Phrase: "associated with lower trait levels."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0441889:Levels [Qualitative Concept]
   760   C0441994:Lower [Spatial Concept]
   760   C0599883:Trait [Organism Attribute]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]
   726 E C0456079:Level [Classification]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1547707:Level [Geographic Area]
   726 E C1706221:Associate [Professional or Occupational Group]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.83: Marker rs2251101 and rs1887922 were tested against fasting glucose levels because the latter was specifically reported on by Karamohamed et al. 

Phrase: "Marker rs2251101"

Phrase: "and"

Phrase: "rs1887922"

Phrase: "were"

Phrase: "tested against fasting glucose levels"
Meta Candidates (Total=17; Excluded=7; Pruned=0; Remaining=10)
   811   C0337438:glucose level test [Laboratory Procedure]
           glucose test
       E   glucose level
   806   C0428548:glucose levels [Laboratory or Test Result]
   781   C0595310:GLUCOSE TEST [Medical Device]
   781   C1275943:fasting test [Laboratory Procedure]
   760   C0015663:Fasting [Finding]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0392366:tested [Intellectual Product]
   760   C0441889:Levels [Qualitative Concept]
   760   C1550565:fasting [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]
   726 E C0456079:Level [Classification]
   726 E C0456962:Fast [Qualitative Concept]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "because"

Phrase: "the latter"

Phrase: "was"

Phrase: "specifically"

Phrase: "reported on"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0684224:Reported [Intellectual Product]
   833   C0700287:Reported [Health Care Activity]
   833   C3496591:Reported [Clinical Attribute]
   799 E C3273238:Report [Intellectual Product]

Phrase: "by Karamohamed et al."
Processing 00000000.tx.84: (10), and these two markers are in extremely high LD (r2 > 0.5) (Fig. 2). 

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "these two markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "are in extremely high LD"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0023746:Linkage Disequilibrium [Quantitative Concept]
   753   C0023745:linkage [Molecular Function]
   753   C0205250:High [Qualitative Concept]
   753   C0281825:Disequilibrium [Finding]
   753   C0394006:Disequilibrium [Disease or Syndrome]
   753   C1299351:High [Qualitative Concept]
   753   C1551058:Are [Quantitative Concept]
   753   C2700149:HIGH [Intellectual Product]

Phrase: "(r2"

Phrase: "> 0.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: ")"

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.85: Neither marker showed evidence of association, but we acknowledge that the present study has less power than the aforementioned one. 

Phrase: "Neither marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005516:Marker [Clinical Attribute]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "evidence of association,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "but"

Phrase: "we"

Phrase: "acknowledge"

Phrase: "that"

Phrase: "the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "power than the aforementioned one."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032863:Power [Human-caused Phenomenon or Process]
   760   C0205447:One [Quantitative Concept]
Processing 00000000.tx.86: The result for rs2251101 upon multiple phenotypes nonetheless supports the likely presence of a primary trait-modifying sequence in the 3' region of IDE, as has been speculated (10). 

Phrase: "The result for rs2251101"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "upon multiple phenotypes nonetheless"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0031437:Phenotypes [Organism Attribute]
   793 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the likely presence of a primary trait-modifying sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the 3' region"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1883633:3' Region [Nucleotide Sequence]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "of IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "speculated"

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.87: The effect of rs1887922 on 2-h insulin levels was significant, however, albeit considerably attenuated in comparison with rs2251101. 

Phrase: "The effect of rs1887922"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on 2-h insulin levels"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   902   C0456948:2 levels [Intellectual Product]
   861   C0202098:insulin levels [Laboratory Procedure]
   861   C0428405:insulin levels [Laboratory or Test Result]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0441889:Levels [Qualitative Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "significant, however,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "albeit"

Phrase: "considerably"

Phrase: "attenuated in comparison"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332161:Attenuated [Qualitative Concept]
   790   C0599946:Attenuated [Activity]
   790   C1707455:Comparison [Activity]

Phrase: "with rs2251101."
Processing 00000000.tx.88: To further explore the effects of rs2251101, a final model was fitted in which rare-allele homozygotes and heterozygotes were combined and compared with common allele homozygotes. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "explore"

Phrase: "the effects of rs2251101,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "a final model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "fitted in which rare-allele homozygotes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0002085:Allele [Gene or Genome]
   753   C0019904:Homozygotes [Organism Attribute]
   753   C0036572:Fit [Sign or Symptom]
   753   C0424576:Fit [Finding]
   753   C0521114:Rare [Temporal Concept]
   753   C0522498:Rare [Qualitative Concept]
   753   C1514917:RARE [Gene or Genome]
   753   C2349186:Fit [Activity]

Phrase: "and"

Phrase: "heterozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygotes [Organism Attribute]

Phrase: "were"

Phrase: "combined"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]

Phrase: "and"

Phrase: "compared with common allele homozygotes."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0002085:Allele [Gene or Genome]
   760   C0019904:Homozygotes [Organism Attribute]
   760   C0205214:Common [Quantitative Concept]
   760   C1522138:Common [Functional Concept]
   760   C1707455:Compared [Activity]
   760   C3245511:common [Intellectual Product]
Processing 00000000.tx.89: The results of this were as follows: F1,366 = 9.1, P = 0.0028; 

Phrase: "The results of this"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "F1,366"

Phrase: "= 9.1,"

Phrase: "P = 0.0028"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.90: F1,363 = 18.4, P = 0.000023; 

Phrase: "F1,363"

Phrase: "= 18.4,"

Phrase: "P = 0.000023"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.91: F1,365 = 7.0, P = 0.0085; 

Phrase: "F1,365"

Phrase: "= 7.0,"

Phrase: "P = 0.0085"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.92: and F1,365 = 11.4, P = 0.0008; 

Phrase: "and"

Phrase: "F1,365"

Phrase: "= 11.4,"

Phrase: "P = 0.0008"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.93: for fasting insulin, 2-h insulin, HOMA-IR, and BMI, respectively. 

Phrase: "for fasting insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "2-h insulin,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
   734   C0011744:2 H [Element, Ion, or Isotope]

Phrase: "HOMA-IR,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   985   C3639411:Homeostatic Model Assessment of Insulin Resistance [Laboratory Procedure]
   833   C1829779:Homeostasis model assessment [Laboratory Procedure]
   833   C1830060:Homeostasis model assessment [Clinical Attribute]
   753   C0019868:Homeostasis [Biologic Function]
   753   C1261322:Assessment [Health Care Activity]
   753   C1516048:Assessment [Activity]
   753   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "BMI,"

Phrase: "respectively."
Processing 00000000.tx.94: Although throughout this study tests were conducted on the combined IGT and normal samples (and a correction applied for possible differences between them), it was considered important to confirm that an effect exists in both populations in at least one analysis. 

Phrase: "Although"

Phrase: "throughout"

Phrase: "this study tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022885:Tests [Laboratory Procedure]
   861   C0392366:Tests [Intellectual Product]
   827 E C0039593:Test [Functional Concept]

Phrase: "were"

Phrase: "conducted on the combined IGT"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   814   C0271650:Impaired glucose tolerance [Disease or Syndrome]
   778   C0178665:Glucose tolerance [Physiologic Function]
   748   C0013220:Tolerance [Finding]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0020963:Tolerance [Pathologic Function]
   748   C0205195:Combined [Qualitative Concept]
   748   C0220929:tolerance [Mental Process]
   748   C0221099:Impaired [Functional Concept]
   748   C0231197:Tolerance [Physiologic Function]
   748   C0684336:Impaired [Pathologic Function]
   748   C1704410:Tolerance [Qualitative Concept]
   714   C0004927:Conduct [Individual Behavior]
   714 E C0336789:Combine [Manufactured Object]

Phrase: "and"

Phrase: "normal samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "("

Phrase: "and"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "applied for possible differences"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0185125:Applied [Health Care Activity]
   770   C0332149:Possible [Qualitative Concept]
   770   C1705910:Possible [Qualitative Concept]
   770   C2362652:Possible [Qualitative Concept]
   737 E C1632850:Apply [Functional Concept]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]
   737 E C1879355:Apply [Functional Concept]

Phrase: "between them"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "important to"

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "an effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "exists in both populations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0032659:Population [Quantitative Concept]
   770   C1257890:Population [Population Group]
   770   C2987476:Exist [Conceptual Entity]

Phrase: "in"

Phrase: "at least one analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
Processing 00000000.tx.95: Using the above model and focusing on the rs2251101 marker and the 2-h insulin trait, significant effects were observed for both the IGT (F1,155 = 13.0, P = 0.0004) and normal (F1,206 = 6.5, P = 0.011) groups; 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the above model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "focusing on the rs2251101 marker"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0000936:focusing [Clinical Attribute]
   760   C2981153:Focusing [Finding]
   726 E C0205234:Focus [Spatial Concept]
   726 E C1285542:focus [Functional Concept]

Phrase: "and"

Phrase: "the 2-h insulin trait,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0599883:Trait [Organism Attribute]

Phrase: "significant effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "observed for both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "the IGT"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0271650:Impaired glucose tolerance [Disease or Syndrome]
   901   C0178665:Glucose tolerance [Physiologic Function]
   827   C0013220:Tolerance [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0020963:Tolerance [Pathologic Function]
   827   C0220929:tolerance [Mental Process]
   827   C0221099:Impaired [Functional Concept]
   827   C0231197:Tolerance [Physiologic Function]
   827   C0684336:Impaired [Pathologic Function]
   827   C1704410:Tolerance [Qualitative Concept]
   771 E C0680282:toleration [Social Behavior]
   755 E C0231198:Tolerant [Functional Concept]

Phrase: "(F1,155"

Phrase: "= 13.0,"

Phrase: "P = 0.0004"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "(F1,206"

Phrase: "= 6.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442749:6/5 [Finding]

Phrase: "P = 0.011"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: ";"
Processing 00000000.tx.96: in both cases the common allele homozygote group had the lowest trait levels. 

Phrase: "in both cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "the common allele homozygote group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "had"

Phrase: "the lowest trait levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.97: View larger version (49K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(49K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.98: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.99: Single-marker quantitative trait tests in men.  

Phrase: "Single-marker quantitative trait"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0599883:Trait [Organism Attribute]

Phrase: "tests in men."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0022885:Test [Laboratory Procedure]
   790   C0025266:Men [Population Group]
   790   C0039593:Test [Functional Concept]
   790   C0392366:Tests [Intellectual Product]
   756 E C0024554:MAN [Finding]
   756 E C0086418:Man [Human]
Processing 00000000.tx.100: In summary, we provide strong evidence that sequence variation within or near IDE contributes to variability in measures of insulin metabolism. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "we"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "strong evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that sequence variation within"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0042333:Sequence Variation [Natural Phenomenon or Process]
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C0205419:Variation [Qualitative Concept]
   770   C1519249:Sequence [Functional Concept]

Phrase: "or"

Phrase: "near IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "contributes to variability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1880177:Contribute [Activity]
   790   C2827666:Variability [Conceptual Entity]
   718 E C0439828:Variable [Qualitative Concept]

Phrase: "in measures"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0079809:Measures [Quantitative Concept]
  1000   C1879489:Measures [Functional Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "of insulin metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547575:insulin metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.101: There are several compelling features to these results. 

Phrase: "There"

Phrase: "are"

Phrase: "several compelling features to these results."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C1521970:Feature [Qualitative Concept]
   719   C1706388:Feature [Conceptual Entity]
   719   C2346469:Feature [Qualitative Concept]
   719   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.102: First, both our study and the study by Karamohamed et al. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "both"

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "the study by Karamohamed et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]
Processing 00000000.tx.103: (10) suggest that a primary functional variant occurs in the 3' region of IDE. 

Phrase: "(10"

Phrase: ")"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a primary functional variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: "occurs in the 3' region of IDE."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0017446:Region [Geographic Area]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0205147:Region [Spatial Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1709305:Occur [Activity]
   742   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.104: In addition, the marker that previously exhibited maximum evidence of association, rs1887922 (10), is in very strong LD with the marker (rs2251101) with the greatest effect in the present study. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005516:Marker [Clinical Attribute]

Phrase: "that previously exhibited maximum evidence of association,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "rs1887922"

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "is in very strong LD"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0023746:Linkage Disequilibrium [Quantitative Concept]
   753   C0023745:linkage [Molecular Function]
   753   C0281825:Disequilibrium [Finding]
   753   C0394006:Disequilibrium [Disease or Syndrome]
   753   C0442821:Strong [Qualitative Concept]
   753   C0442824:Very [Qualitative Concept]

Phrase: "with the marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005516:Marker [Clinical Attribute]

Phrase: "(rs2251101"

Phrase: ")"

Phrase: "with the greatest effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "in the present study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.105: A true pathogenic variant is likely to be in high LD with both of these (and indeed could be one of these markers). 

Phrase: "A true pathogenic variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be in high LD"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   760   C0023745:linkage [Molecular Function]
   760   C0205250:High [Qualitative Concept]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]
   760   C2987476:Be [Conceptual Entity]

Phrase: "with both"

Phrase: "of these"

Phrase: "("

Phrase: "and"

Phrase: "indeed"

Phrase: "could"

Phrase: "be"

Phrase: "one of these markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.106: Second, both of these studies suggest effects either exclusively or predominantly in male subjects. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "both of these studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0238767:Both [Spatial Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C1706086:Both [Qualitative Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "effects either exclusively"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "predominantly in male subjects."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0024554:Male [Finding]
   770   C0086582:male [Population Group]
   770   C1706180:Male [Qualitative Concept]
   770   C1706428:Male [Qualitative Concept]
   770   C1706429:Male [Organism Attribute]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.107: Numerous studies have detected genetic effects exclusively in men (20,21), and sex specificity may be a major confounding factor in genetic analyses (22). 

Phrase: "Numerous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "detected genetic effects exclusively in men (20,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "21"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "sex specificity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0009253:Sex [Organism Function]
   861   C0036864:Sex [Behavior]
   861   C0037791:Specificity [Quantitative Concept]
   861   C0079399:sex [Organism Attribute]
   861   C1314687:Sex [Finding]
   861   C1511884:Specificity [Quantitative Concept]
   861   C1522384:sex [Organism Attribute]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "a major confounding factor in genetic analyses"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   774   C0085801:Factor Analyses [Quantitative Concept]
   774   C0960756:factor A [Organic Chemical]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.108: Third, the marker that was in strongest association with quantitative traits related to Alzheimers disease in our recent study (13) was rs2251101 (from among 26 markers). 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "the marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005516:Marker [Clinical Attribute]

Phrase: "that"

Phrase: "was in strongest association"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0004083:Association [Mental Process]
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]
   770   C1421478:WAS [Gene or Genome]
   737   C0442821:Strong [Qualitative Concept]

Phrase: "with quantitative traits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0599883:traits [Organism Attribute]
   861   C1427926:TRAITS [Gene or Genome]

Phrase: "related to Alzheimers disease"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C0002395:Alzheimers disease [Disease or Syndrome]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   737 E C0163712:Relate [Organic Chemical]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "in our recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "(13"

Phrase: ")"

Phrase: "was"

Phrase: "rs2251101"

Phrase: "("

Phrase: "from among 26 markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.109: Importantly, however, the present analyses suggest that there may be more than one functionally relevant polymorphic site in or near IDE. 

Phrase: "Importantly,"

Phrase: "however,"

Phrase: "the present analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "may"

Phrase: "be"

Phrase: "more than one functionally relevant polymorphic site"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0205145:Site [Spatial Concept]
   748   C0205172:More [Functional Concept]
   748   C0205447:One [Quantitative Concept]
   748   C1515974:Site [Body Location or Region]
   748   C1882417:Polymorphic [Qualitative Concept]
   748   C2347946:Relevant [Qualitative Concept]
   748   C2825164:Site [Spatial Concept]

Phrase: "in"

Phrase: "or"

Phrase: "near IDE."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.110: This is evident in diplotype models, where no single haplotype appears responsible for either elevating or reducing trait levels and where a number of possible interactions are also apparent. 

Phrase: "This"

Phrase: "is"

Phrase: "evident in diplotype models,"

Phrase: "where"

Phrase: "no single haplotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018591:Haplotype [Organism Attribute]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "responsible for either elevating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "or"

Phrase: "reducing trait levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "where"

Phrase: "a number of possible interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "are"

Phrase: "also apparent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750489:apparent [Idea or Concept]
Processing 00000000.tx.111: Evidence of allelic heterogeneity and interaction will in general make fine mapping of the responsible variants a daunting task (23), and this will need to be considered in future studies investigating the IDE region. 

Phrase: "Evidence of allelic heterogeneity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "and"

Phrase: "interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "will in general"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0042950:Will [Mental Process]
   790   C0205246:General [Spatial Concept]
   790   C1553889:General [Idea or Concept]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "fine mapping of the responsible variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1283195:Mapping [Activity]

Phrase: "a daunting task"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540678:Task [Occupational Activity]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "this"

Phrase: "will"

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "considered in future studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0016884:Future [Temporal Concept]
   770   C0750591:considered [Idea or Concept]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "investigating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigating [Functional Concept]

Phrase: "the IDE region."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   756   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.112: We have not directly addressed the question of whether variation in IDE influences the risk for type 2 diabetes. 

Phrase: "We"

Phrase: "have"

Phrase: "not directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "the question of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1522634:Question [Intellectual Product]

Phrase: "whether"

Phrase: "variation in IDE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variation [Qualitative Concept]

Phrase: "influences"

Phrase: "the risk for type 2 diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171304:diabetes risk [Quantitative Concept]
   753   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.113: The two studies that have tested this relationship have produced either no or modest evidence of association, despite examining very large clinical samples. 

Phrase: "The two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "have"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "this relationship"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439849:Relationship [Qualitative Concept]
  1000   C1705630:Relationship [Idea or Concept]
  1000   C1706279:Relationship [Idea or Concept]
  1000   C3540605:Relationship [Intellectual Product]

Phrase: "have"

Phrase: "produced"

Phrase: "either"

Phrase: "no"

Phrase: "or"

Phrase: "modest evidence of association,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "despite"

Phrase: "examining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332128:examining [Finding]
  1000   C2004054:Examining [Activity]

Phrase: "very large clinical samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.114: Our study provides no evidence of association with fasting glucose levels (the primary phenotype used to distinguish diabetic patients). 

Phrase: "Our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "no evidence of association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "with fasting glucose levels"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0015663:Fasting [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1550565:fasting [Intellectual Product]
   793 E C0456079:Level [Classification]
   793 E C0456962:Fast [Qualitative Concept]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "("

Phrase: "the primary phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "distinguish"

Phrase: "diabetic patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: ")."
Processing 00000000.tx.115: Rather, the present data likely capture the fundamental influence of IDE upon circulating insulin levels, whereby a genetically determined deficit in enzyme activity may lead to hyperinsulinemia. 

Phrase: "Rather,"

Phrase: "the present data likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "capture"

Phrase: "the fundamental influence of IDE"

Phrase: "upon circulating insulin levels,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "whereby"

Phrase: "a genetically determined deficit in enzyme activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0162429:Deficit, NOS [Disease or Syndrome]
   748   C2987487:Deficit [Qualitative Concept]

Phrase: "may"

Phrase: "lead to hyperinsulinemia."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0020459:Hyperinsulinaemia [Disease or Syndrome]
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.116: This could manifest itself as a modulator role in type 2 diabetes, but might be more relevant to other phenotypes, such as coronary heart disease (24) and primary hypertension (25). 

Phrase: "This"

Phrase: "could"

Phrase: "manifest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205319:Manifest [Functional Concept]

Phrase: "itself"

Phrase: "as"

Phrase: "a modulator role in type 2 diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "but"

Phrase: "might"

Phrase: "be"

Phrase: "more relevant to other phenotypes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347946:Relevant [Qualitative Concept]

Phrase: "such as coronary heart disease"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0010054:coronary heart disease [Disease or Syndrome]
  1000   C0010068:Coronary heart disease [Disease or Syndrome]
           Coronary Disease
   901   C0018799:Heart disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0018787:Heart [Body Part, Organ, or Organ Component]
           coronary
   827   C1281570:Heart [Body Part, Organ, or Organ Component]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(24"

Phrase: ")"

Phrase: "and"

Phrase: "primary hypertension"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085580:Primary hypertension [Disease or Syndrome]
   861   C0020538:Hypertension [Disease or Syndrome]
   861   C0205225:Primary [Qualitative Concept]
   861   C0439631:Primary [Therapeutic or Preventive Procedure]
   861   C1963138:Hypertension [Finding]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.117: We believe that continued replication efforts in both normal and morbid populations, as well as functional studies, are now highly merited and will be needed to elucidate the molecular basis and clinical relevance of these observed phenotypic effects.  

Phrase: "We"

Phrase: "believe"

Phrase: "that continued replication efforts in both normal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0015264:Effort [Organism Function]

Phrase: "and"

Phrase: "morbid populations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "as well as"

Phrase: "functional studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "now highly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205250:Highly [Qualitative Concept]
   861   C1948052:Now [Temporal Concept]

Phrase: "merited"

Phrase: "and"

Phrase: "will"

Phrase: "be"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elucidate"

Phrase: "the molecular basis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1853126:MOLECULAR BASIS [Idea or Concept]
   861   C1527178:Basis [Functional Concept]
   861   C1874451:Basis [Pharmacologic Substance]

Phrase: "and"

Phrase: "clinical relevance of these observed phenotypic effects."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2347946:Relevance [Qualitative Concept]
Processing 00000000.tx.118: RESEARCH DESIGN AND METHODS TOP ABSTRACT RESEARCH DESIGN AND METHODS REFERENCES  The clinical characteristics of all subjects with IGT and nondiabetic healthy individuals are provided in Table 1. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0086912:methods research [Research Activity]
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The clinical characteristics of all"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0683325:clinical characteristics [Clinical Attribute]
   760   C1521970:Characteristics [Qualitative Concept]

Phrase: "subjects with IGT"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   862   C0271650:Impaired glucose tolerance [Disease or Syndrome]
   806   C0178665:Glucose tolerance [Physiologic Function]
   760   C0013220:Tolerance [Finding]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0020963:Tolerance [Pathologic Function]
   760   C0220929:tolerance [Mental Process]
   760   C0221099:Impaired [Functional Concept]
   760   C0231197:Tolerance [Physiologic Function]
   760   C0681850:Subject [Group]
   760   C0684336:Impaired [Pathologic Function]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1704410:Tolerance [Qualitative Concept]
   760   C1706203:Subject [Idea or Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]
   704 E C0680282:toleration [Social Behavior]

Phrase: "and"

Phrase: "nondiabetic healthy individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0027361:Individual [Population Group]
   793   C0237401:Individual [Human]

Phrase: "are"

Phrase: "provided in Table 1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   770   C1999230:Provided [Activity]
Processing 00000000.tx.119: A total of 321 IGT subjects and 403 nondiabetic control subjects were selected from the Stockholm Diabetes Prevention Program (1618). 

Phrase: "A total of 321 IGT subjects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "403 nondiabetic control subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "selected from the Stockholm Diabetes Prevention Program"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0679717:prevention program [Intellectual Product]
   778   C1659987:diabetes prevention [Educational Activity]
   774   C0814361:selected prevention [Therapeutic or Preventive Procedure]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0199176:Prevention [Therapeutic or Preventive Procedure]
   748   C1706420:PREVENTION [Research Activity]
   748   C1709697:Program [Conceptual Entity]
   748   C2700409:prevention [Qualitative Concept]
   748   C2728259:Program [Pharmacologic Substance]
   748   C3484370:Program [Functional Concept]
   714   C1707391:Select [Activity]

Phrase: "(1618"

Phrase: ")."
Processing 00000000.tx.120: The subjects with IGT were previously diagnosed according to the World Health Organization 1985 criteria and had no medical treatment. 

Phrase: "The subjects with IGT"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "previously"

Phrase: "diagnosed according to the World Health Organization 1985 criteria"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0043237:World Health Organization [Health Care Related Organization]
   764   C0043236:World Health [Idea or Concept]
   764   C0920545:health organization [Health Care Related Organization]
   742   C0011900:Diagnosed [Finding]
   742   C0018684:Health [Idea or Concept]
   742   C0029237:Organisation [Physiologic Function]
   742   C0029246:Organization [Organization]
   742   C0220885:organization [Qualitative Concept]
   742   C0243161:criteria [Intellectual Product]
   742   C0680240:according [Social Behavior]
   742   C1300196:Organization [Functional Concept]
   742   C1522486:Organization [Professional or Occupational Group]
   742   C2700280:World [Population Group]

Phrase: "and"

Phrase: "had"

Phrase: "no medical treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.121: Nondiabetic healthy subjects had normal birth body weight, BMI (<25 kg/m2), and no relatives of first or second degree with diabetes. 

Phrase: "Nondiabetic healthy subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1708335:HEALTHY SUBJECTS [Population Group]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "had"

Phrase: "normal birth body weight,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   923   C0421272:Normal Body Weight [Clinical Attribute]
   923   C0456136:Normal birth weight [Finding]
   923   C1285592:Normal body weight [Clinical Attribute]
   902   C2712185:Normal weight [Finding]
   875   C0005612:Birth Weight [Organism Attribute]
   861   C0005910:Body Weight [Organism Attribute]
           weight
   861   C1305866:body weight [Diagnostic Procedure]
           weight
   812   C0043100:Weight [Quantitative Concept]
   812   C0242821:body [Human]
   812   C0460148:Body [Anatomical Structure]
   812   C1268086:Body [Anatomical Structure]
   812   C1705104:Weight [Idea or Concept]
   729 E C1995017:Bodies [Cell Component]

Phrase: "BMI (<25 kg/m2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456689:kg/m2 [Quantitative Concept]
   812   C0457242:m2 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "no relatives of first"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0557086:No relatives [Finding]
   770   C0080103:Relatives [Family Group]
   737 E C0205345:Relative [Qualitative Concept]
   737 E C1547039:*Relative [Quantitative Concept]

Phrase: "or"

Phrase: "second degree with diabetes."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0443298:Second degree [Qualitative Concept]
   770   C0205436:Second [Quantitative Concept]
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0457385:Second [Temporal Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C0565930:/second [Quantitative Concept]
   770   C1561503:second [Idea or Concept]
   770   C1561545:degree [Quantitative Concept]
   770   C1705190:Second [Qualitative Concept]
   770   C2348088:Degree [Quantitative Concept]
Processing 00000000.tx.122: All participants in the study are of Swedish ancestry and selected from districts in Stockholm. 

Phrase: "All participants in the study"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   781   C0681850:Study Participant [Group]
   781   C2349001:Study Participant [Human]
   760   C0679646:participants [Population Group]
   726 E C2698741:Participant [Classification]

Phrase: "are of Swedish ancestry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1551058:Are [Quantitative Concept]
   770   C1710263:Swedish [Population Group]

Phrase: "and"

Phrase: "selected from districts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1707391:Select [Activity]

Phrase: "in Stockholm."
Processing 00000000.tx.123: Informed consent was received from all subjects, and the study was approved by the local ethics committee of the Karolinska Institute. 

Phrase: "Informed consent"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0021430:Informed Consent [Regulation or Law]
   861   C1511481:Consent [Functional Concept]
   861   C1522154:Informed [Qualitative Concept]
   861   C1554192:consent [Idea or Concept]
   827 E C0537670:Inform [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827 E C0700287:inform [Health Care Activity]
   827 E C1552002:inform [Idea or Concept]

Phrase: "was"

Phrase: "received from all subjects,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1514756:Received [Qualitative Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "approved by the local ethics committee of the Karolinska Institute."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0085546:Ethics Committee [Professional or Occupational Group]
   739   C0015000:Ethics [Idea or Concept]
   739   C0021622:institute [Organization]
   739   C0205276:Local [Spatial Concept]
   739   C0205540:Approved [Qualitative Concept]
   739   C1272753:Institute [Idea or Concept]
   739   C1527243:ethics [Idea or Concept]
   739   C2699414:Committee [Group]
Processing 00000000.tx.124: Genomic DNA was extracted from peripheral blood by using a Puregene DNA purification kit (Gentra, Minneapolis, MN). 

Phrase: "Genomic DNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "extracted from peripheral blood"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0229664:peripheral blood [Body Substance]
           Blood
   791 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   770   C0005767:Blood [Tissue]
   770   C0005768:blood [Body Substance]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C0205100:Peripheral [Spatial Concept]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Puregene DNA purification kit (Gentra,"

Phrase: "Minneapolis,"

Phrase: "MN"

Phrase: ")."
Processing 00000000.tx.125: Quantitative trait measurements. 

Phrase: "Quantitative trait measurements."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242485:measurements [Functional Concept]
Processing 00000000.tx.126: Insulin resistance was assessed by HOMA (26). 

Phrase: "Insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "assessed by HOMA (26"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1516048:Assessed [Activity]

Phrase: ")."
Processing 00000000.tx.127: The HOMA-IR was then calculated in the present study by using the formula of fasting plasma glucose (in millimoles per liter) x fasting plasma insulin (in milliunits per milliliter)/22.5. 

Phrase: "The HOMA-IR"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   932   C3639411:Homeostatic Model Assessment of Insulin Resistance [Laboratory Procedure]
   814   C1829779:Homeostasis model assessment [Laboratory Procedure]
   814   C1830060:Homeostasis model assessment [Clinical Attribute]
   748   C0019868:Homeostasis [Biologic Function]
   748   C1261322:Assessment [Health Care Activity]
   748   C1516048:Assessment [Activity]
   748   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "calculated in the present study"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0150312:Present [Quantitative Concept]
   760   C0444686:Calculated [Functional Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1441506:Calculated [Activity]
   760   C1443182:Calculated [Laboratory Procedure]
   760   C2603343:Study [Research Activity]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the formula of fasting plasma glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0489829:Formula [Intellectual Product]
   753   C1705501:Formula [Intellectual Product]

Phrase: "("

Phrase: "in millimoles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0439190:millimoles [Quantitative Concept]
   916 E C1532563:millimolar [Quantitative Concept]

Phrase: "per liter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475211:liter [Quantitative Concept]

Phrase: ")"

Phrase: "x fasting plasma insulin"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0857690:plasma insulin [Laboratory Procedure]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0032105:Plasma [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "in milliunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1306898:Milliunit [Quantitative Concept]

Phrase: "per milliliter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439242:milliliter [Quantitative Concept]

Phrase: ")"

Phrase: "/22.5."
Processing 00000000.tx.128: SNP selection and verification. 

Phrase: "SNP selection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0036576:selection [Genetic Function]
   756   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]

Phrase: "and"

Phrase: "verification."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237944:Verification [Research Activity]
  1000   C1711411:Verification [Functional Concept]
Processing 00000000.tx.129: The 14 SNPs examined in this study are listed in Table 2, details on which may be found in the dbSNP database (http://www.ncbi.nlm.nih.gov/SNP) under their respective IDs. 

Phrase: "The 14 SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   812   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0032529:polymorphisms [Genetic Function]
   812   C0037179:Single [Population Group]
   812   C0087136:single [Finding]
   812   C0205171:Single [Quantitative Concept]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "examined in this study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332128:Examined [Finding]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "listed in Table 2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C0745732:List [Conceptual Entity]
   737   C3272378:LIST [Intellectual Product]

Phrase: "details on which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1522508:Detail [Qualitative Concept]
   790   C1561567:detail [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "found in the dbSNP database"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0150312:Found [Quantitative Concept]
   760   C0242356:Database [Intellectual Product]
   760   C0993637:Data Base [Intellectual Product]
   760   C1710090:dbSNP [Intellectual Product]
   726 E C0243095:Find [Finding]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.ncbi.nlm.nih.gov/SNP"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   835   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]
   793   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   793   C0032529:Polymorphism [Genetic Function]
   793   C0037179:Single [Population Group]
   793   C0087136:single [Finding]
   793   C0205171:Single [Quantitative Concept]
   793   C1882417:Polymorphism [Qualitative Concept]

Phrase: ")"

Phrase: "under their respective IDs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   777   C1517604:idic [Cell or Molecular Dysfunction]
Processing 00000000.tx.130: Surrounding 50-bp sequences in each direction were examined for repeats and duplicated sequences using RepeatMasker (http://www.repeatmasker.org) and Blast (http://www.ncbi.nlm.nih.gov/blast). 

Phrase: "Surrounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounding [Spatial Concept]

Phrase: "50-bp sequences in each direction"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0162326:Sequences [Nucleotide Sequence]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]

Phrase: "were"

Phrase: "examined for repeats"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205341:repeats [Functional Concept]
   790   C0332128:Examined [Finding]
   790   C1705914:Repeats [Conceptual Entity]
   756 E C1547730:Repeat [Temporal Concept]

Phrase: "and"

Phrase: "duplicated sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RepeatMasker"

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.repeatmasker.org"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522486:ORG [Professional or Occupational Group]

Phrase: ")"

Phrase: "and"

Phrase: "Blast"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337026:Blast [Natural Phenomenon or Process]
  1000   C0368761:blast [Cell]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.ncbi.nlm.nih.gov/blast"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0337026:Blast [Natural Phenomenon or Process]
   799   C0368761:blast [Cell]

Phrase: ")."
Processing 00000000.tx.131: To verify that SNPs were polymorphic in our study populations, each SNP was tested in a set of 32 Swedish control samples. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "that SNPs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:polymorphisms [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "polymorphic in our study populations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882417:Polymorphic [Qualitative Concept]

Phrase: "each SNP"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:Polymorphism [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "was"

Phrase: "tested in a set of 32 Swedish control samples."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   745   C1272570:Test control [Indicator, Reagent, or Diagnostic Aid]
   742   C0036849:Set [Mental Process]
   742   C0243148:control [Qualitative Concept]
   742   C0392366:tested [Intellectual Product]
   742   C1442518:Set [Functional Concept]
   742   C1550141:Control [Substance]
   742   C1705195:Set [Conceptual Entity]
   742   C1710263:Swedish [Population Group]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]
   708 E C0022885:Test [Laboratory Procedure]
   708 E C0039593:Test [Functional Concept]
   708   C0370003:Sample [Substance]
   708   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.132: Assays in which all 32 samples were monomorphic were excluded from further analysis. 

Phrase: "Assays in which"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "all 32 samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "monomorphic"

Phrase: "were"

Phrase: "excluded from further analysis."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1517331:Further [Spatial Concept]
   770   C1524024:analysis [Functional Concept]
   770   C1554077:Excluded [Idea or Concept]
   770   C2828389:Excluded [Activity]
   737 E C0205108:far [Spatial Concept]
   737 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.133: For convenience, the nomenclature used throughout this report to refer to SNPs is the same as that used in our recent report (13). 

Phrase: "For convenience,"

Phrase: "the nomenclature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600281:Nomenclature [Intellectual Product]
  1000   C1524067:Nomenclature [Intellectual Product]

Phrase: "used throughout this report to"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0684224:Report [Intellectual Product]
   760   C0700287:Report [Health Care Activity]
   760   C1273517:used [Finding]
   760   C3273238:Report [Intellectual Product]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "refer to SNPs"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0752046:Single Nucleotide Polymorphisms [Nucleotide Sequence]
   760   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0032529:polymorphisms [Genetic Function]
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C0205543:refer [Functional Concept]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "is"

Phrase: "the same as that"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1278655:SAME AS [Classification]
   770   C0445247:Same [Qualitative Concept]

Phrase: "used in our recent report"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0332185:Recent [Temporal Concept]
   760   C0684224:Report [Intellectual Product]
   760   C0700287:Report [Health Care Activity]
   760   C1273517:used [Finding]
   760   C3273238:Report [Intellectual Product]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.134: Genotyping. 

Phrase: "Genotyping."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285573:Genotyping [Laboratory Procedure]
Processing 00000000.tx.135: Genotyping of SNPs was performed using an induced fluorescence resonance energy transfer modification of dynamic allele-specific hybridization (27,28). 

Phrase: "Genotyping of SNPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1285573:Genotyping [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an induced fluorescence resonance energy transfer modification of dynamic allele-specific hybridization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0392747:Modification [Functional Concept]
   736   C1554963:modification [Qualitative Concept]

Phrase: "(27,"

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.136: All PCRs were run in 10- to 20-l volumes with 1.5 mmol/l MgCl2 and using 520 ng genomic DNA. 

Phrase: "All PCRs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   966   C0677874:pCR [Finding]

Phrase: "were"

Phrase: "run in 10-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C3274438:RUN-IN [Temporal Concept]
   827   C0035953:run [Daily or Recreational Activity]
   827   C0600140:run [Finding]
   827   C1704688:Run [Functional Concept]
   827   C2346414:Run [Finding]

Phrase: "to 20-l volumes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0449468:volumes [Quantitative Concept]
   793 E C1690016:% volume [Qualitative Concept]
   793 E C1705102:Volume [Intellectual Product]
   793 E C2700258:Volume [Laboratory Procedure]

Phrase: "with 1.5 mmol/l MgCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "520 ng genomic DNA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0017428:Genomic [Gene or Genome]
   812   C0887950:genomic [Biomedical Occupation or Discipline]
Processing 00000000.tx.137: All oligonucleotide sequences for dynamic allele-specific hybridization and PCR assays for SNPs have been presented previously (13). 

Phrase: "All oligonucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "sequences for dynamic allele-specific hybridization"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0002085:Allele [Gene or Genome]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0020202:Hybridisation [Genetic Function]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0205369:Specific [Qualitative Concept]
   753   C0729333:Dynamic [Functional Concept]
   753   C1300517:Hybridization [Laboratory Procedure]
   753   C1519249:Sequence [Functional Concept]
   753   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "PCR assays for SNPs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0677874:pCR [Finding]
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "have"

Phrase: "been"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "previously"

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.138: Statistical analysis. 

Phrase: "Statistical analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.139: Deviation from Hardy-Weinberg equilibrium for genotypes at individual loci was assessed using the 2 statistic. 

Phrase: "Deviation from Hardy-Weinberg equilibrium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0012727:Deviation [Spatial Concept]
   760   C0205419:Deviation [Qualitative Concept]
   760   C1705236:Deviation [Finding]

Phrase: "for genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]

Phrase: "at individual loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 2 statistic."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C2348149:Statistic [Quantitative Concept]
   861   C2828391:Statistic [Quantitative Concept]
   789 E C0038215:Statistical [Occupation or Discipline]
Processing 00000000.tx.140: Deviation from normality for trait distributions was assessed using a Kolgomorov-Smirnov test. 

Phrase: "Deviation from normality"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0012727:Deviation [Spatial Concept]
   790   C0205419:Deviation [Qualitative Concept]
   790   C1705236:Deviation [Finding]

Phrase: "for trait distributions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0037775:Distributions [Spatial Concept]
   827 E C0520511:distribution [Idea or Concept]
   827 E C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Kolgomorov-Smirnov test."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
Processing 00000000.tx.141: Correlations between traits were established using Spearmans -statistic. 

Phrase: "Correlations between traits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1707520:Correlation [Qualitative Concept]

Phrase: "were"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Spearmans -statistic."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C2348149:Statistic [Quantitative Concept]
   861   C2828391:Statistic [Quantitative Concept]
   789 E C0038215:Statistical [Occupation or Discipline]
Processing 00000000.tx.142: Tests for association between genotypes and quantitative traits were performed using ANOVA on log-transformed data and included age and group (IGT or normal) as covariates in all analyses. 

Phrase: "Tests for association"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0022885:Tests [Laboratory Procedure]
   790   C0392366:Tests [Intellectual Product]
   756 E C0039593:Test [Functional Concept]

Phrase: "between genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]

Phrase: "and"

Phrase: "quantitative traits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0599883:traits [Organism Attribute]
   861   C1427926:TRAITS [Gene or Genome]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ANOVA on log-transformed data"

Phrase: "and"

Phrase: "included age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "(IGT"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0271650:Impaired glucose tolerance [Disease or Syndrome]
   901   C0178665:Glucose tolerance [Physiologic Function]
   827   C0013220:Tolerance [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0020963:Tolerance [Pathologic Function]
   827   C0220929:tolerance [Mental Process]
   827   C0221099:Impaired [Functional Concept]
   827   C0231197:Tolerance [Physiologic Function]
   827   C0684336:Impaired [Pathologic Function]
   827   C1704410:Tolerance [Qualitative Concept]
   771 E C0680282:toleration [Social Behavior]
   755 E C0231198:Tolerant [Functional Concept]

Phrase: "or"

Phrase: "normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: ")"

Phrase: "as"

Phrase: "covariates in all analyses."
Processing 00000000.tx.143: The above statistical analyses were performed using StatView version 5.0 (Abacus Concepts, Piscataway, NJ). 

Phrase: "The above statistical analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0871424:statistical analysis [Research Activity]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "StatView version 5.0"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0333052:Version [Functional Concept]
   812   C2607870:Version [Spatial Concept]

Phrase: "(Abacus Concepts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178566:concepts [Idea or Concept]

Phrase: "Piscataway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551491:Piscataway [Population Group]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")."
Processing 00000000.tx.144: Haplotype frequencies were estimated using the HAPLOTYPER program (29). 

Phrase: "Haplotype frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "were"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the HAPLOTYPER program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.145: LD between marker pairs was estimated using the r2 metric (30).  

Phrase: "LD between marker pairs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   760   C0023745:linkage [Molecular Function]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "was"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the r2"

Phrase: "metric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0699680:Metric [Organic Chemical,Pharmacologic Substance]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.146: ACKNOWLEDGMENTS  This study was supported by the Novo Nordisk Consortium, the Swedish Research Council, the Loo and Hans Osterman Foundation, the Vetenskapligt Arbete Inom Diabetologi Foundation, and the Swedish Diabetes Association. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "supported by the Novo Nordisk Consortium,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0331875:Novo Nordisk [Health Care Related Organization]
   753   C1513822:Consortium [Professional or Occupational Group]
   753   C1521721:Supported [Conceptual Entity]
   753   C1880171:Consortium [Professional or Occupational Group]
   719 E C0183683:Support [Medical Device]

Phrase: "the Swedish Research Council,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C1551807:Council [Population Group]

Phrase: "the Loo"

Phrase: "and"

Phrase: "Hans Osterman Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "the Vetenskapligt Arbete Inom Diabetologi Foundation,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   804   C0016617:Foundation [Organization]
   721 E C0002055:base [Inorganic Chemical]
   721 E C0178499:Base [Chemical Viewed Functionally]
   721 E C1626935:Bases [Quantitative Concept]
   721 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "the Swedish Diabetes Association."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
Processing 00000000.tx.147: We thank all of the subjects for participating in the present study, Dr. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "all of the subjects"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "for participating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679823:Participating [Functional Concept]

Phrase: "in the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.148: Bo Ding and Ylva Behr for valuable discussion, and Camilla Lagerberg and Yvonne Strmberg for excellent assistance.  

Phrase: "Bo Ding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419419:DING [Gene or Genome]

Phrase: "and"

Phrase: "Ylva Behr for valuable discussion,"

Phrase: "and"

Phrase: "Camilla Lagerberg"

Phrase: "and"

Phrase: "Yvonne Strmberg for excellent assistance."
Processing 00000000.tx.149: FOOTNOTES  HOMA-IR, homeostasis model assessment of insulin resistance; 

Phrase: "FOOTNOTES  HOMA-IR,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   932   C3639411:Homeostatic Model Assessment of Insulin Resistance [Laboratory Procedure]
   814   C1829779:Homeostasis model assessment [Laboratory Procedure]
   814   C1830060:Homeostasis model assessment [Clinical Attribute]
   748   C0019868:Homeostasis [Biologic Function]
   748   C1261322:Assessment [Health Care Activity]
   748   C1516048:Assessment [Activity]
   748   C3161035:Model [Intellectual Product]

Phrase: "homeostasis model assessment of insulin resistance"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   985   C3639411:Homeostatic Model Assessment of Insulin Resistance [Laboratory Procedure]
   833   C1829779:Homeostasis model assessment [Laboratory Procedure]
   833   C1830060:Homeostasis model assessment [Clinical Attribute]
   753   C0019868:Homeostasis [Biologic Function]
   753   C1261322:Assessment [Health Care Activity]
   753   C1516048:Assessment [Activity]
   753   C3161035:Model [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.150: IDE, insulin-degrading enzyme; 

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.151: IGT, impaired glucose tolerance; 

Phrase: "IGT,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0271650:Impaired glucose tolerance [Disease or Syndrome]
   901   C0178665:Glucose tolerance [Physiologic Function]
   827   C0013220:Tolerance [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0020963:Tolerance [Pathologic Function]
   827   C0220929:tolerance [Mental Process]
   827   C0221099:Impaired [Functional Concept]
   827   C0231197:Tolerance [Physiologic Function]
   827   C0684336:Impaired [Pathologic Function]
   827   C1704410:Tolerance [Qualitative Concept]
   771 E C0680282:toleration [Social Behavior]
   755 E C0231198:Tolerant [Functional Concept]

Phrase: "impaired glucose tolerance"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0271650:Impaired glucose tolerance [Disease or Syndrome]
   901   C0178665:Glucose tolerance [Physiologic Function]
   827   C0013220:Tolerance [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0020963:Tolerance [Pathologic Function]
   827   C0220929:tolerance [Mental Process]
   827   C0221099:Impaired [Functional Concept]
   827   C0231197:Tolerance [Physiologic Function]
   827   C0684336:Impaired [Pathologic Function]
   827   C1704410:Tolerance [Qualitative Concept]
   771 E C0680282:toleration [Social Behavior]
   755 E C0231198:Tolerant [Functional Concept]

Phrase: ";"
Processing 00000000.tx.152: LD, linkage disequilibrium; 

Phrase: "LD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "linkage disequilibrium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0023746:Linkage Disequilibrium [Quantitative Concept]
   861   C0023745:linkage [Molecular Function]
   861   C0281825:Disequilibrium [Finding]
   861   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.153: SNP, single nucleotide polymorphism. 

Phrase: "SNP,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:Polymorphism [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   827   C1882417:Polymorphism [Qualitative Concept]

Phrase: "single nucleotide polymorphism."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0752046:Single Nucleotide Polymorphism [Nucleotide Sequence]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0032529:Polymorphism [Genetic Function]
   827   C0037179:Single [Population Group]
   827   C0087136:single [Finding]
   827   C0205171:Single [Quantitative Concept]
   827   C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.154: Address correspondence and reprint requests to Suad Efendic, Rolf Luft Center for Diabetes Research, Department of Molecular Medicine, L6:B2, Karolinska Hospital, SE-171 76, Stockholm, Sweden. 

Phrase: "Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Suad Efendic,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0686900:request [Functional Concept]
   770   C1272683:Request [Functional Concept]
   770   C1522634:Request [Intellectual Product]

Phrase: "Rolf Luft Center for Diabetes Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0683939:center research [Manufactured Object,Organization]
   753   C0205099:Center [Spatial Concept]

Phrase: "Department of Molecular Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "L6:B2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0507114:B2 [Body Part, Organ, or Organ Component]
   861   C1416271:B2 [Gene or Genome]

Phrase: "Karolinska Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "SE-171 76,"

Phrase: "Stockholm,"

Phrase: "Sweden."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]
Processing 00000000.tx.155: E-mail: suad.efendic{at}molmed.ki.se Received for publication February 23, 2003 and accepted in revised form April 22, 2004  REFERENCES TOP ABSTRACT RESEARCH DESIGN AND METHODS REFERENCES  Meigs JB, Panhuysen CI, Myers RH, Wilson PW, Cupples LA: A genome-wide scan for loci linked to plasma levels of glucose and HbA1c in a community-based sample of Caucasian pedigrees: the Framingham Offspring Study. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "suad.efendic{at}molmed.ki.se"

Phrase: "Received for publication February 23,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C0450348:23 [Quantitative Concept]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2003"

Phrase: "and"

Phrase: "accepted in revised form April 22,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1272684:Accepted [Qualitative Concept]
   753   C1522492:Form [Functional Concept]
   753   C1527075:Revised [Therapeutic or Preventive Procedure]
   753   C1548435:Accepted [Idea or Concept]
   719 E C1548601:Accept [Idea or Concept]

Phrase: "2004"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035171:Research Design [Research Activity]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1707689:Design [Activity]
   812   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Meigs JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Panhuysen CI,"

Phrase: "Myers RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Wilson PW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242397:PW [Geographic Area]

Phrase: "Cupples LA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: ":"

Phrase: "A genome-wide scan for loci"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C1517519:Genome Scan [Molecular Biology Research Technique]
   753   C0017428:Genome [Gene or Genome]
   753   C0034606:Scan [Diagnostic Procedure]
   753   C0332464:Wide [Spatial Concept]
   753   C0441633:Scan [Diagnostic Procedure]
   753   C2338314:Genome [Conceptual Entity]
   753   C2826292:SCAN [Finding]

Phrase: "linked to plasma levels of glucose"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   814   C0455280:glucose levels plasma [Laboratory or Test Result]
           glucose plasma
   783   C0202042:Plasma glucose [Laboratory Procedure]
   783   C0428548:glucose levels [Laboratory or Test Result]
   767 E C0337438:glucose level [Laboratory Procedure]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0032105:Plasma [Body Substance]
   753   C0441889:Levels [Qualitative Concept]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   719 E C0456079:Level [Classification]
   719   C1517892:Link [Intellectual Product]
   719 E C1547707:Level [Geographic Area]
   719   C1704666:Link [Intellectual Product]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "HbA1c in a community-based sample of Caucasian pedigrees"

Phrase: ":"

Phrase: "the Framingham Offspring Study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0557651:Study [Manufactured Object]
   827   C0680063:Offspring [Family Group]
   827   C2603343:Study [Research Activity]
   827   C3166866:Framingham [Intellectual Product]
Processing 00000000.tx.156: Diabetes51 :833 840,2002[Abstract/Free FullText] Wiltshire S, Hattersley AT, Hitman GA, Walker M, Levy JC, Sampson M, ORahilly S, Frayling TM, Bell JI, Lathrop GM, Bennett A, Dhillon R, Fletcher C, Groves CJ, Jones E, Prestwich P, Simecek N, Rao PV, Wishart M, Bottazzo GF, Foxon R, Howell S, Smedley D, Cardon LR, Menzel S, McCarthy MI: A genomewide scan for loci predisposing to type 2 diabetes in a U. 

Phrase: "Diabetes51"

Phrase: ":"

Phrase: "833 840,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wiltshire S,"

Phrase: "Hattersley AT,"

Phrase: "Hitman GA,"

Phrase: "Walker M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Levy JC,"

Phrase: "Sampson M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "ORahilly S,"

Phrase: "Frayling TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Bell JI,"

Phrase: "Lathrop GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Bennett A,"

Phrase: "Dhillon R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Fletcher C,"

Phrase: "Groves CJ,"

Phrase: "Jones E,"

Phrase: "Prestwich P,"

Phrase: "Simecek N,"

Phrase: "Rao PV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032463:PV [Neoplastic Process]

Phrase: "Wishart M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bottazzo GF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016703:GF [Geographic Area]
   861   C1551081:gf [Quantitative Concept]

Phrase: "Foxon R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Howell S,"

Phrase: "Smedley D,"

Phrase: "Cardon LR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023617:LR [Geographic Area]
   861   C2986899:LR [Idea or Concept]

Phrase: "Menzel S,"

Phrase: "McCarthy MI"

Phrase: ":"

Phrase: "A genomewide scan for loci"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0034606:Scan [Diagnostic Procedure]
   760   C0441633:Scan [Diagnostic Procedure]
   760   C2826292:SCAN [Finding]

Phrase: "predisposing to type 2 diabetes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0231203:predisposing [Functional Concept]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "in a U."
Processing 00000000.tx.157: K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. 

Phrase: "K. population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "("

Phrase: "the Diabetes UK Warren 2 Repository"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0872261:Repository [Manufactured Object]

Phrase: ")"

Phrase: ":"

Phrase: "analysis of 573 pedigrees"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "independent replication of a susceptibility locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0598312:Replication [Genetic Function]
   753   C1883725:replication [Qualitative Concept]

Phrase: "on chromosome 1q."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1327882:chromosome 1q [Nucleotide Sequence]
           1q
Processing 00000000.tx.158: Am J Hum Genet69 :553 569,2001[Medline] Ghosh S, Watanabe RM, Valle TT, Hauser ER, Magnuson VL, Langefeld CD, Ally DS, Mohlke KL, Silander K, Kohtamaki K, Chines P, Balow J Jr, Birznieks G, Chang J, Eldridge W, Erdos MR, Karanjawala ZE, Knapp JI, Kudelko K, Martin C, Morales-Mena A, Musick A, Musick T, Pfahl C, Porter R, Rayman JB: The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. 

Phrase: "Am"

Phrase: "J Hum Genet69"

Phrase: ":"

Phrase: "553 569,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ghosh S,"

Phrase: "Watanabe RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Valle TT,"

Phrase: "Hauser ER,"

Phrase: "Magnuson VL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0228339:VL [Body Part, Organ, or Organ Component]
   861   C1424729:VL [Gene or Genome]
   861   C1858854:VL [Disease or Syndrome]

Phrase: "Langefeld CD,"

Phrase: "Ally DS,"

Phrase: "Mohlke KL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1366480:KL [Gene or Genome]
   861   C1416656:KL [Gene or Genome]

Phrase: "Silander K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kohtamaki K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Chines P,"

Phrase: "Balow J Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "Birznieks G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Chang J,"

Phrase: "Eldridge W,"

Phrase: "Erdos MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Karanjawala ZE,"

Phrase: "Knapp JI,"

Phrase: "Kudelko K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Martin C,"

Phrase: "Morales-Mena A,"

Phrase: "Musick A,"

Phrase: "Musick T,"

Phrase: "Pfahl C,"

Phrase: "Porter R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Rayman JB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: ":"

Phrase: "The Finland-United States investigation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C1261322:Investigation [Health Care Activity]
   812   C1552578:investigation [Idea or Concept]
   741 E C1517586:Investigational [Qualitative Concept]
   741 E C3245491:investigational [Intellectual Product]

Phrase: "of non-insulin-dependent diabetes mellitus genetics"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0596425:diabetes mellitus genetics [Occupation or Discipline]
   799   C0017398:Genetics [Biomedical Occupation or Discipline]
   799   C0017399:genetics [Biologic Function]
   780   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
   780   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   734   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]

Phrase: "(FUSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332466:Fusion [Functional Concept]
  1000   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.159: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.160: An autosomal genome scan for genes that predispose to type 2 diabetes. 

Phrase: "An autosomal genome scan for genes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1517519:Genome Scan [Molecular Biology Research Technique]
   753   C0017428:Genome [Gene or Genome]
   753   C0034606:Scan [Diagnostic Procedure]
   753   C0441633:Scan [Diagnostic Procedure]
   753   C2338314:Genome [Conceptual Entity]
   753   C2826292:SCAN [Finding]

Phrase: "that"

Phrase: "predispose to type 2 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.161: Am J Hum Genet67 :1174 1185,2000[Medline] Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL, Leach RJ, OConnell P, Stern MP: Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. 

Phrase: "Am"

Phrase: "J Hum Genet67"

Phrase: ":"

Phrase: "1174 1185,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duggirala R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Blangero J,"

Phrase: "Almasy L,"

Phrase: "Dyer TD,"

Phrase: "Williams KL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1366480:KL [Gene or Genome]
   861   C1416656:KL [Gene or Genome]

Phrase: "Leach"

Phrase: "RJ,"

Phrase: "OConnell P,"

Phrase: "Stern MP"

Phrase: ":"

Phrase: "Linkage of type 2 diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0023745:linkage [Molecular Function]
   716   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
   716   C2984301:Type II diabetes mellitus [Functional Concept]

Phrase: "and of age at onset"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   835   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]
   760   C0332162:Onset [Qualitative Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "to a genetic location"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450429:Location [Spatial Concept]
   861   C1515974:Location [Body Location or Region]

Phrase: "on chromosome 10q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520266:10q [Nucleotide Sequence]

Phrase: "in Mexican Americans."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025884:Mexican Americans [Population Group]
   861   C0596070:americans [Population Group]
Processing 00000000.tx.162: Am J Hum Genet64 :1127 1140,1999[Medline] Duckworth WC, Bennett RG, Hamel FG: Insulin degradation: progress and potential. 

Phrase: "Am"

Phrase: "J Hum Genet64"

Phrase: ":"

Phrase: "1127 1140,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: ":"

Phrase: "Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3547574:insulin degradation [Molecular Function]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: ":"

Phrase: "progress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1272688:progress [Functional Concept]
  1000   C1280477:Progress [Functional Concept]

Phrase: "and"

Phrase: "potential."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.163: Endocr Rev19 :608 624,1998[Abstract/Free FullText] Affholter JA, Cascieri MA, Bayne ML, Brange J, Casaretto M, Roth RA: Identification of residues in the insulin molecule important for binding to insulin-degrading enzyme. 

Phrase: "Endocr Rev19"

Phrase: ":"

Phrase: "608 624,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Affholter JA,"

Phrase: "Cascieri MA,"

Phrase: "Bayne ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Brange J,"

Phrase: "Casaretto M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Roth RA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: ":"

Phrase: "Identification of residues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "in the insulin molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "important for binding"

Phrase: "to insulin-degrading enzyme."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.164: Biochemistry29 :7727 7733,1990[Medline] Affholter JA, Hsieh CL, Francke U, Roth RA: Insulin-degrading enzyme: stable expression of the human complementary DNA, characterization of its protein product, and chromosomal mapping of the human and mouse genes. 

Phrase: "Biochemistry29"

Phrase: ":"

Phrase: "7727 7733,"

Phrase: "1990"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Affholter JA,"

Phrase: "Hsieh CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Francke U,"

Phrase: "Roth RA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: ":"

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "stable expression of the human complementary DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "characterization of its protein product,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "chromosomal mapping of the human"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0008630:Chromosome Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   760   C1283195:Mapping [Activity]

Phrase: "and"

Phrase: "mouse genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.165: Mol Endocrinol4 :1125 1135,1990[Abstract] Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S: Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. 

Phrase: "Mol Endocrinol4"

Phrase: ":"

Phrase: "1125 1135,"

Phrase: "1990"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Farris W,"

Phrase: "Mansourian S,"

Phrase: "Chang Y,"

Phrase: "Lindsley L,"

Phrase: "Eckman EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Frosch MP,"

Phrase: "Eckman CB,"

Phrase: "Tanzi RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Selkoe DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Guenette S"

Phrase: ":"

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulates"

Phrase: "the levels of insulin,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   819   C0202098:insulin levels [Laboratory Procedure]
   819   C0428405:insulin levels [Laboratory or Test Result]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "amyloid beta-protein,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0078939:Amyloid beta-Protein [Amino Acid, Peptide, or Protein]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C1750295:beta protein [Genetic Function]
   901   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "and"

Phrase: "the beta-amyloid precursor protein intracellular domain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   839   C0162808:Protein Domain [Spatial Concept]
   839   C1514562:Protein Domain [Amino Acid Sequence]
   799   C0175996:intracellular [Cell Component]
   799   C0178719:Intracellular [Spatial Concept]
   799   C1880389:Domain [Functional Concept]
   799   C1883221:Domain [Conceptual Entity]
   799   C3541951:Domain [Intellectual Product]
   734   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
   700   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.166: Proc Natl Acad Sci U S A100 :4162 4167,2003[Abstract/Free FullText] Fakhrai-Rad H, Nikoshkov A, Kamel A, Fernstrom M, Zierath JR, Norgren S, Luthman H, Galli J: Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats. 

Phrase: "Proc Natl Acad Sci U S A100"

Phrase: ":"

Phrase: "4162 4167,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fakhrai-Rad H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Nikoshkov A,"

Phrase: "Kamel A,"

Phrase: "Fernstrom M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Zierath JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Norgren S,"

Phrase: "Luthman H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Galli J"

Phrase: ":"

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "identified as a candidate diabetes susceptibility gene"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0919453:Susceptibility Gene [Gene or Genome]
   774   C1332838:Candidate Gene [Gene or Genome]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0012655:Susceptibility [Clinical Attribute]
   748   C0017337:Gene [Gene or Genome]
   748   C0205396:Identified [Qualitative Concept]
   748   C0220898:Susceptibility [Organism Attribute]
   748   C1264642:Susceptibility [Functional Concept]
   748   C1547045:*Susceptibility [Quantitative Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]

Phrase: "in GK rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.167: Hum Mol Genet9 :2149 2158,2000[Abstract/Free FullText] Karamohamed S, Demissie S, Volcjak J, Liu C, Heard-Costa N, Liu J, Shoemaker CM, Panhuysen CI, Meigs JB, Wilson P, Atwood LD, Cupples LA, Herbert A: Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study. 

Phrase: "Hum Mol Genet9"

Phrase: ":"

Phrase: "2149 2158,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Karamohamed S,"

Phrase: "Demissie S,"

Phrase: "Volcjak J,"

Phrase: "Liu C,"

Phrase: "Heard-Costa N,"

Phrase: "Liu J,"

Phrase: "Shoemaker CM,"

Phrase: "Panhuysen CI,"

Phrase: "Meigs JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Wilson P,"

Phrase: "Atwood LD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0023746:Linkage Disequilibrium [Quantitative Concept]
   827   C0023745:linkage [Molecular Function]
   827   C0281825:Disequilibrium [Finding]
   827   C0394006:Disequilibrium [Disease or Syndrome]

Phrase: "Cupples LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Herbert A"

Phrase: ":"

Phrase: "Polymorphisms in the insulin-degrading enzyme gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0678951:gene polymorphisms [Genetic Function]
   748   C0032529:polymorphisms [Genetic Function]
   714 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "are"

Phrase: "associated with type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]

Phrase: "from the NHLBI Framingham Heart Study."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0489835:Heart study [Diagnostic Procedure]
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]
Processing 00000000.tx.168: Diabetes52 :1562 1567,2003[Abstract/Free FullText] Groves CJ, Wiltshire S, Smedley D, Owen KR, Frayling TM, Walker M, Hitman GA, Levy JC, ORahilly S, Menzel S, Hattersley AT, McCarthy MI: Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility. 

Phrase: "Diabetes52"

Phrase: ":"

Phrase: "1562 1567,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Groves CJ,"

Phrase: "Wiltshire S,"

Phrase: "Smedley D,"

Phrase: "Owen KR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022773:KR [Geographic Area]

Phrase: "Frayling TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Walker M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hitman GA,"

Phrase: "Levy JC,"

Phrase: "ORahilly S,"

Phrase: "Menzel S,"

Phrase: "Hattersley AT,"

Phrase: "McCarthy MI"

Phrase: ":"

Phrase: "Association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "haplotype analysis of the insulin-degrading enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "(IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "gene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "a strong positional"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0240795:POSITIONAL [Finding]
   789 E C0733755:Position [Spatial Concept]

Phrase: "and"

Phrase: "biological candidate for type 2 diabetes susceptibility."
Processing 00000000.tx.169: Diabetes52 :1300 1305,2003[Abstract/Free FullText] Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, Ueda H, Cordell HJ, Eaves IA, Dudbridge F, Twells RC, Payne F, Hughes W, Nutland S, Stevens H, Carr P, Tuomilehto-Wolf E, Tuomilehto J, Gough SC, Clayton DG, Todd JA: Haplotype tagging for the identification of common disease genes. 

Phrase: "Diabetes52"

Phrase: ":"

Phrase: "1300 1305,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Johnson GC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3537453:GC [Gene or Genome]

Phrase: "Esposito L,"

Phrase: "Barratt BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Smith"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "AN,"

Phrase: "Heward J,"

Phrase: "Di Genova G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Ueda H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Cordell HJ,"

Phrase: "Eaves IA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1947960:Ia [Mammal]

Phrase: "Dudbridge F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Twells RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "Payne F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Hughes W,"

Phrase: "Nutland S,"

Phrase: "Stevens H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Carr P,"

Phrase: "Tuomilehto-Wolf E,"

Phrase: "Tuomilehto J,"

Phrase: "Gough SC,"

Phrase: "Clayton DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Todd JA"

Phrase: ":"

Phrase: "Haplotype tagging for the identification of common disease genes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   708   C0037293:Tag [Neoplastic Process]
   708   C0181496:Tag [Manufactured Object]
   708   C1710492:TAG [Gene or Genome]
Processing 00000000.tx.170: Nat Genet29 :233 237,2001[Medline] Prince JA, Feuk L, Gu HF, Gatz M, Blennow K, Brookes AJ: Genetic variation in a haplotype block spanning IDE, KNSL1 and HHEX influences Alzheimers disease. 

Phrase: "Nat Genet29"

Phrase: ":"

Phrase: "233 237,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Prince JA,"

Phrase: "Feuk L,"

Phrase: "Gu HF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018488:Hf [Element, Ion, or Isotope]
   861   C1538440:HF [Gene or Genome]
   861   C3273279:HF [Gene or Genome]

Phrase: "Gatz M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Blennow K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Brookes AJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: ":"

Phrase: "Genetic variation in a haplotype block spanning IDE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0042333:Genetic Variation [Natural Phenomenon or Process]
   739   C0205419:Variation [Qualitative Concept]

Phrase: "KNSL1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416693:KNSL1 [Gene or Genome]
  1000   C2697835:KNSL1 [Gene or Genome]

Phrase: "and"

Phrase: "HHEX"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415537:HHEX [Gene or Genome]

Phrase: "influences"

Phrase: "Alzheimers disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.171: Hum Mutat22 :363 371,2003[Medline] Patil N, Berno AJ, Hinds DA, Barrett WA, Doshi JM, Hacker CR, Kautzer CR, Lee DH, Marjoribanks C, McDonough DP, Nguyen BT, Norris MC, Sheehan JB, Shen N, Stern D, Stokowski RP, Thomas DJ, Trulson MO, Vyas KR, Frazer KA: Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. 

Phrase: "Hum Mutat22"

Phrase: ":"

Phrase: "363 371,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Patil N,"

Phrase: "Berno AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Hinds DA,"

Phrase: "Barrett WA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043038:WA [Geographic Area]

Phrase: "Doshi JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Hacker CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "Kautzer CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "Lee DH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1832586:DH [Disease or Syndrome]

Phrase: "Marjoribanks C,"

Phrase: "McDonough DP,"

Phrase: "Nguyen BT,"

Phrase: "Norris MC,"

Phrase: "Sheehan JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Shen N,"

Phrase: "Stern D,"

Phrase: "Stokowski RP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538326:RP [Gene or Genome]
   861   C3541325:RP [Idea or Concept]

Phrase: "Thomas DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Trulson MO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538743:MO [Idea or Concept]

Phrase: "Vyas KR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022773:KR [Geographic Area]

Phrase: "Frazer KA"

Phrase: ":"

Phrase: "Blocks of limited haplotype diversity"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0028778:blocks [Pathologic Function]
   760   C0332206:Blocks [Functional Concept]
   760   C1533157:Blocks [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]

Phrase: "revealed by high-resolution scanning of human chromosome 21."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   764   C0008643:Human Chromosome [Cell Component]
   764   C0008664:Chromosome 21 [Cell Component]
   764   C1719039:High resolution [Laboratory Procedure]
   742   C0008633:Chromosome [Cell Component]
   742   C0034606:Scanning [Diagnostic Procedure]
   742   C0086418:Human [Human]
   742   C0205250:High [Qualitative Concept]
   742   C0441633:Scanning [Diagnostic Procedure]
   742   C0443289:Revealed [Qualitative Concept]
   742   C1299351:High [Qualitative Concept]
   742   C1514893:Resolution [Idea or Concept]
   742   C1706463:Resolution [Quantitative Concept]
   742   C2699488:Resolution [Conceptual Entity]
   742   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.172: Science294 :1719 1723,2001[Abstract/Free FullText] Horne BD, Camp NJ: Principal component analysis for selection of optimal SNP-sets that capture intragenic variation. 

Phrase: "Science294"

Phrase: ":"

Phrase: "1719 1723,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Horne BD,"

Phrase: "Camp NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: ":"

Phrase: "Principal component analysis for selection of optimal SNP-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   799   C3536614:Single nucleotide polymorphism analysis [Laboratory Procedure]
   782   C0429865:Principal Component Analysis [Quantitative Concept]
   782   C1704235:Principal component analysis [Quantitative Concept]
   760   C1882460:Principal Component [Quantitative Concept]
   757   C0796451:polymorphism analysis [Diagnostic Procedure]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0205225:Principal [Qualitative Concept]
   739   C0401925:Principal [Professional or Occupational Group]
   739   C0449432:Component [Manufactured Object]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]
   739   C1705248:Component [Conceptual Entity]

Phrase: "sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "that capture intragenic variation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variation [Qualitative Concept]
Processing 00000000.tx.173: Genet Epidemiol26 :11 21,2004[Medline] Carlsson S, Persson P-G, Grill V, Alvarsson M, Efendic S, Norman A, Svanstrm L, stenson C-G: Weight history, glucose tolerance and insulin levels in middle-aged Swedish men. 

Phrase: "Genet Epidemiol26"

Phrase: ":"

Phrase: "11 21,"

Phrase: "2004"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Carlsson S,"

Phrase: "Persson P-G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Grill V,"

Phrase: "Alvarsson M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Efendic S,"

Phrase: "Norman A,"

Phrase: "Svanstrm L,"

Phrase: "stenson C-G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ":"

Phrase: "Weight history,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0019664:History [Occupation or Discipline]
   861   C0019665:history [Intellectual Product]
   861   C0262512:History, NOS [Organism Attribute]
   861   C0262926:History [Finding]
   861   C1705255:History [Conceptual Entity]
   861   C2004062:History [Finding]
   789 E C1552658:Historical [Idea or Concept]
   789 E C1552723:Historical [Idea or Concept]

Phrase: "glucose tolerance"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0178665:Glucose tolerance [Physiologic Function]
   861   C0013220:Tolerance [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0020963:Tolerance [Pathologic Function]
   861   C0220929:tolerance [Mental Process]
   861   C0231197:Tolerance [Physiologic Function]
   861   C1704410:Tolerance [Qualitative Concept]
   805 E C0680282:toleration [Social Behavior]
   789 E C0231198:Tolerant [Functional Concept]

Phrase: "and"

Phrase: "insulin levels in middle-aged Swedish men."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0202098:insulin levels [Laboratory Procedure]
   778   C0428405:insulin levels [Laboratory or Test Result]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0441889:Levels [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.174: Am J Epidemiology148 :539 545,1998[Abstract] Grill V, Persson G, Carlsson S, Norman A, Alvarsson M, stensson C-G, Svanstrm L, Efendic S: Family history of diabetes middle-aged Swedish men is a gender unrelated factor which associated with insulinopenia in newly diagnosed diabetic subjects. 

Phrase: "Am"

Phrase: "J Epidemiology148"

Phrase: ":"

Phrase: "539 545,"

Phrase: "1998"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Grill V,"

Phrase: "Persson G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Carlsson S,"

Phrase: "Norman A,"

Phrase: "Alvarsson M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "stensson C-G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Svanstrm L,"

Phrase: "Efendic S"

Phrase: ":"

Phrase: "Family history of diabetes middle-aged Swedish men"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0019874:Family of man [Mammal]
   778   C0086418:FAMILY OF MAN [Human]
   770   C0241889:Family history [Finding]
   770   C1705495:Family History [Idea or Concept]
   744   C0015576:Family [Family Group]
   744   C0019664:History [Occupation or Discipline]
   744   C0019665:history [Intellectual Product]
   744   C0262512:History, NOS [Organism Attribute]
   744   C0262926:History [Finding]
   744   C1704727:Family [Conceptual Entity]
   744   C1705255:History [Conceptual Entity]
   744   C2004062:History [Finding]

Phrase: "is"

Phrase: "a gender unrelated factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "which"

Phrase: "associated with insulinopenia"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in newly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750546:newly [Idea or Concept]

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "diabetic subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]
Processing 00000000.tx.175: Diabetologia42 :15 23,1999 Agardh EE, Ahlbom A, Andersson T, Efendic S, Grill V, Hallqvist J, Norman A, Ostenson CG: Work stress and low sense of coherence is associated with type 2 diabetes in middle-aged Swedish women. 

Phrase: "Diabetologia42"

Phrase: ":"

Phrase: "15 23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "1999 Agardh EE,"

Phrase: "Ahlbom A,"

Phrase: "Andersson T,"

Phrase: "Efendic S,"

Phrase: "Grill V,"

Phrase: "Hallqvist J,"

Phrase: "Norman A,"

Phrase: "Ostenson CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: ":"

Phrase: "Work stress"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0344330:Work stress [Finding]
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "low sense of coherence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C3178983:Sense of Coherence [Mental Process]
           Coherence Sense
   770   C0036658:sense [Organ or Tissue Function]

Phrase: "is"

Phrase: "associated with type 2 diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C0011860:Type 2 Diabetes [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0441730:Type 2 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in middle-aged Swedish women."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0043210:Women [Population Group]
Processing 00000000.tx.176: Diabetes Care26 :719 724,2003[Abstract/Free FullText] Zondervan KT, Cardon LR: The complex interplay among factors that influence allelic association. 

Phrase: "Diabetes Care26"

Phrase: ":"

Phrase: "719 724,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zondervan KT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1690540:KT [Qualitative Concept]
   861   C3484384:Kt [Quantitative Concept]

Phrase: "Cardon LR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0023617:LR [Geographic Area]
   861   C2986899:LR [Idea or Concept]

Phrase: ":"

Phrase: "The complex interplay among factors"

Phrase: "that"

Phrase: "influence"

Phrase: "allelic association."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]
Processing 00000000.tx.177: Nat Rev Genet5 :89 100,2004[Medline] ODonnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH, Levy D: Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. 

Phrase: "Nat Rev Genet5"

Phrase: ":"

Phrase: "89 100,"

Phrase: "2004"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] ODonnell CJ,"

Phrase: "Lindpaintner K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Larson MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Rao"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412430:RAO [Gene or Genome]

Phrase: "VS"

Phrase: ","

Phrase: "Ordovas JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Schaefer EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Myers RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Levy D"

Phrase: ":"

Phrase: "Evidence for association"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332120:Evidence [Functional Concept]

Phrase: "and"

Phrase: "genetic linkage of the angiotensin-converting enzyme locus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0023745:genetic linkage [Molecular Function]
           linkage
   767   C0678933:Genetic Locus [Gene or Genome]
   744   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   744   C0314603:Genetic [Functional Concept]

Phrase: "with hypertension"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020538:Hypertension [Disease or Syndrome]
  1000   C1963138:Hypertension [Finding]

Phrase: "and"

Phrase: "blood pressure in men"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0005823:Blood Pressure [Organism Function]
   833   C1271104:Blood Pressure [Finding]
   833   C1272641:Blood pressure [Finding]
   770   C0005767:Blood [Tissue]
   770   C0005768:blood [Body Substance]
   770   C0033095:Pressure [Phenomenon or Process]
   770   C0229664:Blood [Body Substance]
   770   C0460139:Pressure [Finding]
   770   C1306345:Pressure [Functional Concept]

Phrase: "but"

Phrase: "not women in the Framingham Heart Study."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0043210:Women [Population Group]
Processing 00000000.tx.178: Circulation97 :1766 1772,1998[Abstract/Free FullText] Wittrup HH, Tybjaerg-Hansen A, Steffensen R, Deeb SS, Brunzell JD, Jensen G, Nordestgaard BG: Mutations in the lipoprotein lipase gene associated with ischemic heart disease in men: the Copenhagen city heart study. 

Phrase: "Circulation97"

Phrase: ":"

Phrase: "1766 1772,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wittrup HH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0062941:HH [Organic Chemical,Pharmacologic Substance]
   861   C1384665:HH [Gene or Genome]
   861   C1414862:Hh [Gene or Genome]

Phrase: "Tybjaerg-Hansen A,"

Phrase: "Steffensen R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Deeb SS,"

Phrase: "Brunzell JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Jensen G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Nordestgaard BG"

Phrase: ":"

Phrase: "Mutations in the lipoprotein lipase gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with ischemic heart disease"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   862   C0010054:ischaemic heart disease [Disease or Syndrome]
   862   C0151744:Ischaemic heart disease [Disease or Syndrome]
   862   C1313980:Ischemic heart disease [Finding]
   806   C0018799:Heart disease [Disease or Syndrome]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C0243083:associated disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0018787:Heart [Body Part, Organ, or Organ Component]
   760   C0475224:Ischaemic [Functional Concept]
   760   C1281570:Heart [Body Part, Organ, or Organ Component]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "in men"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0025266:Men [Population Group]
   966 E C0024554:MAN [Finding]
   966 E C0086418:Man [Human]

Phrase: ":"

Phrase: "the Copenhagen city heart study."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0489835:Heart study [Diagnostic Procedure]
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]
Processing 00000000.tx.179: Arterioscler Thromb Vasc Biol19 :1535 1540,1999[Abstract/Free FullText] McCarthy JJ, Meyer J, Moliterno DJ, Newby LK, Rogers WJ, Topol EJ: Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients. 

Phrase: "Arterioscler Thromb Vasc Biol19"

Phrase: ":"

Phrase: "1535 1540,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] McCarthy JJ,"

Phrase: "Meyer J,"

Phrase: "Moliterno DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Newby LK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038088:LK [Geographic Area]
   861   C2681928:LK [Gene or Genome]

Phrase: "Rogers WJ,"

Phrase: "Topol EJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: ":"

Phrase: "Evidence for substantial effect modification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "by gender"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079399:Gender [Organism Attribute]
  1000   C0804628:Gender [Clinical Attribute]
  1000   C1522384:Gender [Organism Attribute]

Phrase: "in a large-scale genetic association study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C2717878:Study, Genetic Association [Molecular Biology Research Technique]
   853   C2827447:Genetic Study [Research Activity]
   804   C0557651:Study [Manufactured Object]
   804   C2603343:Study [Research Activity]

Phrase: "of the metabolic syndrome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0524620:Metabolic syndrome [Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   861   C0311400:Metabolic [Functional Concept]
   861   C1524026:Metabolic [Cell Function]
   861   C2707259:Metabolic [Clinical Attribute]

Phrase: "among coronary heart disease patients."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0030705:Patients [Patient or Disabled Group]
   756   C0010054:coronary heart disease [Disease or Syndrome]
   756   C0010068:Coronary heart disease [Disease or Syndrome]
           Coronary Disease
Processing 00000000.tx.180: Hum Genet114 :87 98,2003[Medline] Cox R, Bouzekri N, Martin S, Southam L, Hugill A, Golamaully M, Cooper R, Adeyemo A, Soubrier F, Ward R: Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides. 

Phrase: "Hum Genet114"

Phrase: ":"

Phrase: "87 98,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cox R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bouzekri N,"

Phrase: "Martin S,"

Phrase: "Southam L,"

Phrase: "Hugill A,"

Phrase: "Golamaully M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Cooper R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Adeyemo A,"

Phrase: "Soubrier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Ward R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Angiotensin-1-converting enzyme (ACE) plasma concentration"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0683150:plasma concentration [Quantitative Concept]
   799   C0086045:Concentration [Mental Process]
   799   C1446561:Concentration [Quantitative Concept]
   727 E C1880165:Concentrated [Biomedical or Dental Material]
   700   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]

Phrase: "is"

Phrase: "influenced"

Phrase: "by multiple ACE-linked quantitative trait nucleotides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.181: Hum Mol Genet11 :2969 2977,2002[Abstract/Free FullText] Despres JP, Lamarche B, Mauriege P, Cantin B, Lupien PJ, Dagenais GR: Risk factors for ischaemic heart disease: is it time to measure insulin? 

Phrase: "Hum Mol Genet11"

Phrase: ":"

Phrase: "2969 2977,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Despres JP,"

Phrase: "Lamarche B,"

Phrase: "Mauriege P,"

Phrase: "Cantin B,"

Phrase: "Lupien PJ,"

Phrase: "Dagenais GR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]

Phrase: ":"

Phrase: "Risk factors for ischaemic heart disease"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   820   C1113667:heart disease risk [Finding]
   814   C0850664:disease factors risk [Finding]
   790   C0035648:risk factors [Quantitative Concept]
   790   C1553898:risk factors [Idea or Concept]
   783   C0679238:disease factors [Functional Concept]
   783   C1281905:disease risk [Finding]
   753   C0035647:Risk [Qualitative Concept]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: ":"

Phrase: "is"

Phrase: "it time to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "insulin?"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.182: (Editorial). 

Phrase: "(Editorial"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282412:Editorial [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.183: Eur Heart J17 :1453 1454,1996[Medline] Andersen UB, Olsen MH, Dige-Petersen H, Ibsen H: Exercise blood pressure is related to insulin resistance in subjects with two hypertensive parents. 

Phrase: "Eur Heart J17"

Phrase: ":"

Phrase: "1453 1454,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Andersen UB,"

Phrase: "Olsen MH,"

Phrase: "Dige-Petersen H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Ibsen H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Exercise blood pressure"
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
   901   C0005823:Blood Pressure [Organism Function]
   901   C1271104:Blood Pressure [Finding]
   901   C1272641:Blood pressure [Finding]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0033095:Pressure [Phenomenon or Process]
   827   C0229664:Blood [Body Substance]
   827   C0460139:Pressure [Finding]
   827   C1306345:Pressure [Functional Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "is"

Phrase: "related to insulin resistance"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   833   C0021655:Insulin Resistance [Pathologic Function]
   833   C2700570:INSULIN RESISTANCE [Gene or Genome]
   783   C0332325:Resistant to [Functional Concept]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0237834:Resistance [Mental Process]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C1514892:Resistance [Physiologic Function]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0163712:Relate [Organic Chemical]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "with two hypertensive parents."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0030551:Parents [Family Group]
   793 E C2699423:Parent [Conceptual Entity]
Processing 00000000.tx.184: Blood Press12 :314 318,2003[Medline] Matthews DR, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. 

Phrase: "Blood Press12"

Phrase: ":"

Phrase: "314 318,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Matthews DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Rudenski AS,"

Phrase: "Naylor BA,"

Phrase: "Treacher DF,"

Phrase: "Turner RC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: ":"

Phrase: "Homeostasis model assessment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1829779:Homeostasis model assessment [Laboratory Procedure]
  1000   C1830060:Homeostasis model assessment [Clinical Attribute]
   827   C0019868:Homeostasis [Biologic Function]
   827   C1261322:Assessment [Health Care Activity]
   827   C1516048:Assessment [Activity]
   827   C3161035:Model [Intellectual Product]

Phrase: ":"

Phrase: "insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "beta-cell function from fasting plasma glucose"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C0007613:Cell Function [Cell Function]
   778   C0030281:Beta cell [Cell]
   774   C0032112:Plasma cell [Cell]
   748   C0007634:Cell [Cell]
   748   C0031843:function [Physiologic Function]
   748   C0330390:Beta [Plant]
   748   C0439096:Beta [Intellectual Product]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1705273:Function [Intellectual Product]
   748   C1948049:Cell [Spatial Concept]
   748   C2004068:Beta [Qualitative Concept]

Phrase: "and"

Phrase: "insulin concentrations in man."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.185: Diabetologia28 :412 419,1985[Medline] Jobs M, Howell WM, Stromqvist L, Mayr T, Brookes AJ: DASH-2: flexible, low-cost, and high-throughput SNP genotyping by dynamic allele-specific hybridization on membrane arrays. 

Phrase: "Diabetologia28"

Phrase: ":"

Phrase: "412 419,"

Phrase: "1985"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jobs M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Howell WM,"

Phrase: "Stromqvist L,"

Phrase: "Mayr T,"

Phrase: "Brookes AJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: ":"

Phrase: "DASH-2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0002085:Allele [Gene or Genome]
   804   C0020202:Hybridisation [Genetic Function]
   804   C0205369:Specific [Qualitative Concept]
   804   C0729333:Dynamic [Functional Concept]
   804   C1300517:Hybridization [Laboratory Procedure]
   804   C1552740:specific [Intellectual Product]

Phrase: ":"

Phrase: "flexible, low-cost,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0010186:Cost [Quantitative Concept]
   827   C0205251:low [Qualitative Concept]
   827   C0220812:cost [Quantitative Concept]
   827   C1299352:Low [Qualitative Concept]
   827   C1550472:low [Idea or Concept]

Phrase: "and"

Phrase: "high-throughput SNP genotyping by dynamic allele-specific hybridization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1285573:Genotyping [Laboratory Procedure]

Phrase: "on membrane arrays."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510941:Array [Spatial Concept]
Processing 00000000.tx.186: Genome Res13 :916 924,2003[Abstract/Free FullText] Prince JA, Feuk L, Howell WM, Jobs M, Emahazion T, Blennow K, Brookes AJ: Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation. 

Phrase: "Genome Res13"

Phrase: ":"

Phrase: "916 924,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Prince JA,"

Phrase: "Feuk L,"

Phrase: "Howell WM,"

Phrase: "Jobs M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Emahazion T,"

Phrase: "Blennow K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Brookes AJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: ":"

Phrase: "Robust"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986815:Robust [Qualitative Concept]

Phrase: "and"

Phrase: "accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1285573:Genotyping [Laboratory Procedure]

Phrase: ":"

Phrase: "design criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243161:criteria [Intellectual Product]

Phrase: "and"

Phrase: "assay validation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519941:Validation [Research Activity]
Processing 00000000.tx.187: Genome Res11 :152 162,2001[Abstract/Free FullText] Niu T, Qin ZS, Xu X, Liu JS: Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. 

Phrase: "Genome Res11"

Phrase: ":"

Phrase: "152 162,"

Phrase: "2001"

Phrase: "[Abstract/Free FullText"

Phrase: "] Niu T,"

Phrase: "Qin ZS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043459:ZS [Congenital Abnormality,Disease or Syndrome]

Phrase: "Xu X,"

Phrase: "Liu JS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0679201:Inference [Mental Process]
Processing 00000000.tx.188: Am J Hum Genet70 :157 169,2002[Medline] Hill WG: Estimation of linkage disequilibrium in randomly mating populations. 

Phrase: "Am"

Phrase: "J Hum Genet70"

Phrase: ":"

Phrase: "157 169,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hill WG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043092:WG [Disease or Syndrome]

Phrase: ":"

Phrase: "Estimation of linkage disequilibrium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0680844:estimation [Mental Process]
   770   C0681916:Estimation [Quantitative Concept]
   770   C0750572:Estimation [Quantitative Concept]

Phrase: "in randomly mating populations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
Processing 00000000.tx.189: Heredity33 :229 239,1974[Medline]

Phrase: "Heredity33"

Phrase: ":"

Phrase: "229 239,"

Phrase: "1974"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

